Abstract Library

The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.

1

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2021 Jul;73(7):924-939. doi: 10.1002/acr.24596. Epub 2021 Jun 8.

Liana Fraenkel 1Joan M Bathon 2Bryant R England 3E William St Clair 4Thurayya Arayssi 5Kristine Carandang 6Kevin D Deane 7Mark Genovese 8Kent Kwas Huston 9Gail Kerr 10Joel Kremer 11Mary C Nakamura 12Linda A Russell 13Jasvinder A Singh 14Benjamin J Smith 15Jeffrey A Sparks 16Shilpa Venkatachalam 17Michael E Weinblatt 16Mounir Al-Gibbawi 18Joshua F Baker 19Kamil E Barbour 20Jennifer L Barton 21Laura Cappelli 22Fatimah Chamseddine 18Michael George 23Sindhu R Johnson 24Lara Kahale 18Basil S Karam 18Assem M Khamis 18Iris Navarro-Millán 25Reza Mirza 26Pascale Schwab 21Namrata Singh 27Marat Turgunbaev 28Amy S Turner 28Sally Yaacoub 18Elie A Akl 18

2

"Associations of Rheumatoid Arthritis and Depressive Symptoms over Time: Are there Differences by Education, Race/Ethnicity, and Gender?"

Arthritis Care Res (Hoboken). 2021 Jun 13. doi: 10.1002/acr.24730. Online ahead of print.

Julia T McQuillan 1Jennifer A Andersen 2Terceira A Berdahl 3Jeff Willett 4

3

The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions

Front Pharmacol. 2021 May 28;12:680043. doi: 10.3389/fphar.2021.680043.eCollection 2021.

Shahin Shams 1Joseph M Martinez 2John R D Dawson 3Juan Flores 4Marina Gabriel 1Gustavo Garcia 1Amanda Guevara 2Kaitlin Murray 5Noah Pacifici 1Maxemiliano V Vargas 6Taylor Voelker 3Johannes W Hell 2Judith F Ashouri 7

4

The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis

Cardiovasc Endocrinol Metab. 2021 Feb 19;10(2):125-131.doi: 10.1097/XCE.0000000000000244. eCollection 2021 Jun.

Zixing Tian 1John Mclaughlin 1Arpana Verma 2Hector Chinoy 3 4 5Adrian H Heald 1 1

5

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Arthritis Rheumatol. 2021 Jul;73(7):1108-1123. doi: 10.1002/art.41752. Epub 2021 Jun 8

Liana Fraenkel 1Joan M Bathon 2Bryant R England 3E William St Clair 4Thurayya Arayssi 5Kristine Carandang 6Kevin D Deane 7Mark Genovese 8Kent Kwas Huston 9Gail Kerr 10Joel Kremer 11Mary C Nakamura 12Linda A Russell 13Jasvinder A Singh 14Benjamin J Smith 15Jeffrey A Sparks 16Shilpa Venkatachalam 17Michael E Weinblatt 16Mounir Al-Gibbawi 18Joshua F Baker 19Kamil E Barbour 20Jennifer L Barton 21Laura Cappelli 22Fatimah Chamseddine 18Michael George 23Sindhu R Johnson 24Lara Kahale 18Basil S Karam 18Assem M Khamis 18Iris Navarro-Millán 25Reza Mirza 26Pascale Schwab 21Namrata Singh 27Marat Turgunbaev 28Amy S Turner 28Sally Yaacoub 18Elie A Akl 18

6

Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door

J Rheumatol. 2021 Jun 1;jrheum.210224. doi: 10.3899/jrheum.210224.Online ahead of print.

Jeffrey A Sparks 1

7

Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom

Rheumatology (Oxford). 2021 Jun 3;keab464. doi: 10.1093/rheumatology/keab464.Online ahead of print.

Peter C Taylor 1Matthew Woods 2Catherine Rycroft 2Priya Patel 3Sophee Blanthorn-Hazell 3Toby Kent 3Marwan Bukhari 4

8

What Is the Persistence to Methotrexate in Rheumatoid Arthritis, and Does Machine Learning Outperform Hypothesis-Based Approaches to Its Prediction?

ACR Open Rheumatol. 2021 Jul;3(7):457-463. doi: 10.1002/acr2.11266. Epub 2021 Jun 4.

Helga Westerlind 1Mateusz Maciejewski 2Thomas Frisell 1Scott A Jelinsky 2Daniel Ziemek 2Johan Askling 1

9

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Ann Rheum Dis. 2021 May 28;annrheumdis-2021-220418.doi: 10.1136/annrheumdis-2021-220418. Online ahead of print.

Jeffrey A Sparks # 1 2Zachary S Wallace # 3 4Andrea M Seet 5Milena A Gianfrancesco 5Zara Izadi 6Kimme L Hyrich 7 8Anja Strangfeld 9Laure Gossec 10 11Loreto Carmona 12Elsa F Mateus 13 14Saskia Lawson-Tovey 15 16Laura Trupin 5Stephanie Rush 5Patricia Katz 5Gabriela Schmajuk 5 17Lindsay Jacobsohn 5Leanna Wise 18Emily L Gilbert 19Ali Duarte-García 20Maria O Valenzuela-Almada 21Guillermo J Pons-Estel 22Carolina A Isnardi 22Guillermo A Berbotto 23Tiffany Y-T Hsu 24Kristin M D'Silva 4Naomi J Patel 4Lianne Kearsley-Fleet 7Martin Schäfer 9Sandra Lúcia Euzébio Ribeiro 25Samar Al Emadi 26Liselotte Tidblad 27Carlo Alberto Scirè 28Bernd Raffeiner 29Thierry Thomas 30René-Marc Flipo 31Jérôme Avouac 32Raphaèle Seror 33Miguel Bernardes 34 35Maria Margarida Cunha 36

10

Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals

Arthritis Rheumatol. 2021 May 5;10.1002/art.41800. doi: 10.1002/art.41800. Online ahead of print.

Bryant R England 1 2Punyasha Roul 2Yangyuna Yang 2Andre C Kalil 3Kaleb Michaud 2 4Geoffrey M Thiele 1 2Brian C Sauer 5Joshua F Baker 6Ted R Mikuls 1 2

11

Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests

J Rheumatol. 2021 May 15;jrheum.201510. doi: 10.3899/jrheum.201510.Online ahead of print.

Johannes W G Jacobs 1Maxime M A Verhoeven 1Paco M J Welsing 1

12

Systematic review and meta-analysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis

J Rheumatol. 2021 May 15;jrheum.201439. doi: 10.3899/jrheum.201439. Online ahead of print.

Sanketh Rampes 1Vishit Patel 1Ailsa Bosworth 1Clare Jacklin 1Deepak Nagra 1Mark Yates 1Sam Norton 1James Galloway 1

13

Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis

Front Immunol. 2021 Apr 29;12:673916. doi: 10.3389/fimmu.2021.673916.eCollection 2021.

Sally A Clayton 1 2Lucy MacDonald 3 4Mariola Kurowska-Stolarska 3 4Andrew R Clark 1 2

14

Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis

Ann Rheum Dis. 2021 May 28;annrheumdis-2021-220125.doi: 10.1136/annrheumdis-2021-220125. Online ahead of print.

Tate M Johnson 1 2Harlan R Sayles 1 3Joshua F Baker 4 5Michael D George 4 5Punyasha Roul 1Cheng Zheng 3Brian Sauer 6 7Katherine P Liao 8Daniel R Anderson 9Ted R Mikuls 1 2Bryant R England 10 2

15

Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning

J Rheumatol. 2021 May 1;jrheum.201626. doi: 10.3899/jrheum.201626. Online ahead of print.

Fredrik D Johansson 1Jamie E Collins 1Vincent Yau 1Hongshu Guan 1Seoyoung C Kim 1Elena Losina 1David Sontag 1Jacklyn Stratton 1Huong Trinh 1Jeffrey Greenberg 1Daniel H Solomon 1

16

The utility of therapeutic plasma exchange in Hyperviscosity syndrome associated with juvenile rheumatoid arthritis: A case report

J Clin Apher. 2021 May 4. doi: 10.1002/jca.21903. Online ahead of print.

Allen P Green 1Adam C Gonzalez 2Jack B Alperin 3James D Burner 1Sean G Yates 1

17

Clinical use of Jak 1 inhibitors for rheumatoid arthritis

Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii31-ii38.doi: 10.1093/rheumatology/keab265.

Peter Nash 1

18

Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis

Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii17-ii23.doi: 10.1093/rheumatology/keaa823.

Eduardo Mysler 1Ana Lizarraga 1

19

Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort

Int Immunopharmacol. 2021 Apr 29;97:107719. doi: 10.1016/j.intimp.2021.107719.Online ahead of print.

Bryant R England 1Megan Campany 2Harlan Sayles 2Punyasha Roul 2Yangyuna Yang 2Apar Kishor Ganti 3Jeremy Sokolove 4William H Robinson 5Andreas M Reimold 6Gail S Kerr 7Grant W Cannon 8Brian C Sauer 8Joshua F Baker 9Geoffrey M Thiele 10Ted R Mikuls 10

20

Identification and Evaluation of Serum Protein Biomarkers Which Differentiate Psoriatic from Rheumatoid Arthritis

Arthritis Rheumatol. 2021 Jun 11. doi: 10.1002/art.41899. Online ahead of print.

Angela Mc Ardle 1Anna Kwasnik 1Agnes Szenpetery 1Belinda Hernandez 2 3Andrew Parnell 3Wilco de Jager 4 5Sytze de Roock 5Oliver FitzGerald 1Stephen R Pennington 1

21

Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study

Medicine (Baltimore). 2021 Apr 30;100(17):e25481. doi: 10.1097/MD.0000000000025481.

Alberto Floris 1Daniela Perra 1Ignazio Cangemi 1Mattia Congia 1Elisabetta Chessa 1Maria Maddalena Angioni 1Arduino Aleksander Mangoni 2Gian Luca Erre 3Alessandro Mathieu 1Matteo Piga 1Alberto Cauli 3

22

Clinical and biomechanical factors associated with falls and rheumatoid arthritis: baseline cohort with longitudinal nested case-control study

Rheumatology (Oxford). 2021 Apr 26;keab388. doi: 10.1093/rheumatology/keab388.Online ahead of print.

Toby O Smith 1 2Celia Clarke 1Jack R Dainty 1Laura Watts 1Max Yates 1 3Valerie M Pomeroy 1 4Emma Stanmore 5Terence W O'Neill Tw 6Alexander J Macgregor 1 3

23

Perioperative Management of Antirheumatic Medications in Patients with RA and SLE Undergoing Elective Foot and Ankle Surgery: A Critical Analysis Review

JBJS Rev. 2021 Jun 8;9(6). doi: 10.2106/JBJS.RVW.20.00201.

Noah E Saunders 1James R Holmes 2David M Walton 2Paul G Talusan 3

24

Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)

RMD Open. 2021 Jun;7(2):e001673. doi: 10.1136/rmdopen-2021-001673.

Stanley B Cohen 1Janet Pope 2Boulos Haraoui 3Eduardo Mysler 4Annette Diehl 5Tatjana Lukic 6Shixue Liu 7Lori Stockert 5Rebecca Germino 6Sujatha Menon 8Harry Shi 6Edward C Keystone 9

25

Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors

Rheumatology (Oxford). 2021 Apr 19;keab355. doi: 10.1093/rheumatology/keab355.Online ahead of print.

Roy Fleischmann 1Mark C Genovese 2Karina Maslova 3Henry Leher 4Amy Praestgaard 5Gerd R Burmester 6

26

Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial

RMD Open. 2021 Apr;7(1):e001627. doi: 10.1136/rmdopen-2021-001627.

Juliana Rachel Hoeper 1 2Jan Zeidler 1Sara Eileen Meyer 2Georg Gauler 3Patricia Steffens-Korbanka 3Martin Welcker 4Jörg Wendler 5Florian Schuch 5Ulrich von Hinüber 6Andreas Schwarting 7 8Torsten Witte 2Dirk Meyer-Olson 2 9Kirsten Hoeper 10

27

Demyelinating Events Following Initiation of Anti-TNFa Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis

Neurol Neuroimmunol Neuroinflamm. 2021 Apr 16;8(3):e992.doi: 10.1212/NXI.0000000000000992. Print 2021 May.

Thomas R P Taylor 1James Galloway 1Rebecca Davies 1Kimme Hyrich 1Ruth Dobson 2

28

Epstein-Barr virus -related lymphoma in rheumatoid arthritis: Implications for long-term usage of immunosuppressive drugs and review of the literature

Intern Med J. 2021 May 24. doi: 10.1111/imj.15390. Online ahead of print.

Jianna He 1Luke Williamson 1Ken Cai 1Peter Wong 1 2Allan Sturgess 3John Taper 4Nicholas Manolios 1 5

29

Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study

Rheumatol Ther. 2021 May 24. doi: 10.1007/s40744-021-00317-9. Online ahead of print.

Alvin F Wells 1Bochao Jia 2Li Xie 2Guillermo J Valenzuela 3Edward C Keystone 4Zhanguo Li 5Amanda K Quebe 6Kirstin Griffing 2Susan Otawa 2Boulos Haraoui 7

30

Few Adverse Cardiovascular Events among Patients with Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured?

Arthritis Rheumatol. 2021 May 13. doi: 10.1002/art.41801. Online ahead of print.

Candace H Feldman 1Mark S Link 2

31

Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID19 Pandemic in a Community Practice-Based Network

Arthritis Care Res (Hoboken). 2021 May 10. doi: 10.1002/acr.24626. Online ahead of print.

Michael George 1Maria I Danila 2Daniel Watrous 3Shanmugapriya Reddy 4Jeffrey Alper 5Fenglong Xie 2W Benjamin Nowell 6Joel Kallich 7Cassie Clinton 2Kenneth G Saag 2Jeffrey R Curtis 2

32

Meaningful change thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) fatigue and pain interference scores in patients with rheumatoid arthritis

J Rheumatol. 2021 Mar 15;jrheum.200990. doi: 10.3899/jrheum.200990. Online ahead of print.

Jennifer L Beaumont 1Elizabeth S Davis 1James F Fries 1Jeffrey R Curtis 1David Cella 1Huifeng Yun 1

33

Role of Janus Kinase inhibitors in rheumatoid arthritis treatment

Curr Opin Rheumatol. 2021 May 1;33(3):300-306. doi: 10.1097/BOR.0000000000000792.

Virginia Reddy 1 2Stanley Cohen 1 3 4

34

Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials

Rheumatol Ther. 2021 Apr 2. doi: 10.1007/s40744-021-00302-2. Online ahead of print.

Catherine B McGuiness 1Natalie N Boytsov 2Xiang Zhang 2Xin Wang 3Carol L Kannowski 2Rolin L Wade 3

35

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25.

Dimitrios A Pappas 1Taylor Blachley 2Jennie H Best 3Steve Zlotnick 3William G Reiss 3Kelechi Emeanuru 2Joel M Kremer 2 4

36

The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease

Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020.

Livia Savarese 1Maria Francesca Freda 1Raffaele De Luca Picione 2Pasqaule Dolce 3Raffaella De Falco 4Maria Alessio 5Mauro Cancian 6Adriana Franzese 5Maria Domenica Guarino 7Roberto Perricone 7Angelica Petraroli 8Riccardo Senter 1Claudia Traverso 5Andrea Zanichelli 9Eugenio Zito 10Maria Bova 5

37

Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups

J Clin Med. 2021 Apr 1;10(7):1403. doi: 10.3390/jcm10071403.

Barbara Hauser 1 2Nerea Alonso 2Philip L Riches 1 2

38

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25.

Dimitrios A Pappas 1Taylor Blachley 2Jennie H Best 3Steve Zlotnick 3William G Reiss 3Kelechi Emeanuru 2Joel M Kremer 2 4

39

The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease

Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020.

Livia Savarese 1Maria Francesca Freda 1Raffaele De Luca Picione 2Pasqaule Dolce 3Raffaella De Falco 4Maria Alessio 5Mauro Cancian 6Adriana Franzese 5Maria Domenica Guarino 7Roberto Perricone 7Angelica Petraroli 8Riccardo Senter 1Claudia Traverso 5Andrea Zanichelli 9Eugenio Zito 10Maria Bova 5

40

Discrepancy Between Multi-Biomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2021 Feb 28. doi: 10.1002/acr.24583. Online ahead of print.

Roy Fleischmann 1Jingyu Liu 2Julie Zhu 2Oscar G Segurado 3Daniel E Furst 4

41

The association between increased body mass index and response to conventional synthetic DMARD treatment in rheumatoid arthritis: Results from the METEOR database

Rheumatology (Oxford). 2021 Apr 30;keab389. doi: 10.1093/rheumatology/keab389.Online ahead of print.

Mrinalini Dey 1 2Sizheng S Zhao 1 2Robert J Moots 2 3Sytske Anne Bergstra 4Robert B Landewe 5 6Nicola J Goodson 2

42

Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial

ACR Open Rheumatol. 2021 May 1. doi: 10.1002/acr2.11256. Online ahead of print.

Jon T Giles 1Pamela M Rist 2Katherine P Liao 2Ahmed Tawakol 3Zahi A Fayad 4Venkatesh Mani 4Nina P Paynter 2Paul M Ridker 2Robert J Glynn 2Fengxin Lu 5Rachel Broderick 1Meredith Murray 5Kathleen M M Vanni 5Daniel H Solomon 2Joan M Bathon 1

43

Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic

Expert Rev Clin Immunol. 2021 Apr 14;1-11. doi: 10.1080/1744666X.2021.1908887.Online ahead of print.

Ennio Giulio Favalli 1Gabriella Maioli 1Martina Biggioggero 1Roberto Caporali 1 2

44

Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study

Patient Prefer Adherence. 2021 Feb 17;15:359-373. doi: 10.2147/PPA.S289692. eCollection 2021.

Peter C Taylor 1Codrina Ancuta 2Orsolya Nagy 3María C de la Vega 4Andrey Gordeev 5Radka Janková 6Umut Kalyoncu 7Ivan Lagunes-Galindo 3Jadranka Morovic-Vergles 8Mariana Peixoto G U E Silva de Souza 9Bernadette Rojkovich 10Prodromos Sidiropoulos 11Atsushi Kawakami 12

45

Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof

J Med Chem. 2021 Feb 25;64(4):2228-2241. doi: 10.1021/acs.jmedchem.0c01952.Epub 2021 Feb 11.

Ryan R Davis 1Baoli Li 1Sang Y Yun 2Alice Chan 1Pradeep Nareddy 1Steven Gunawan 1Muhammad Ayaz 2Harshani R Lawrence 2Gary W Reuther 3Nicholas J Lawrence 1Ernst Schönbrunn 1

46

Managing Cardiovascular Risk in Patients with Rheumatic Disease

Med Clin North Am. 2021 Mar;105(2):247-262. doi: 10.1016/j.mcna.2020.09.010.Epub 2021 Jan 14.

Lyn D Ferguson 1Naveed Sattar 2Iain B McInnes 3

47

Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights

Expert Rev Clin Pharmacol. 2021 Apr 13;1-10. doi: 10.1080/17512433.2021.1913050.Online ahead of print.

Maria Gabriella Raimondo 1Martina Biggioggero 2Lavinia Agra Coletto 3Andreas Ramming 1Roberto Caporali 2 3Ennio Giulio Favalli 2

48

Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail!

Arthritis Rheumatol. 2021 Mar 28. doi: 10.1002/art.41746. Online ahead of print.

Janet E Pope 1Peter Nash 2Roy Fleischmann 3

49

Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study

Osteoporos Int. 2021 Feb 11. doi: 10.1007/s00198-021-05862-1. Online ahead of print.

J Erwin 1D G Enki 2A D Woolf 3

50

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871.Epub 2020 May 29.

Milena Gianfrancesco # 1Kimme L Hyrich # 2 3Sarah Al-Adely 2 3Loreto Carmona 4Maria I Danila 5Laure Gossec 6 7Zara Izadi 1Lindsay Jacobsohn 1Patricia Katz 1Saskia Lawson-Tovey 3 8Elsa F Mateus 9Stephanie Rush 1Gabriela Schmajuk 1Julia Simard 10Anja Strangfeld 11Laura Trupin 1Katherine D Wysham 12Suleman Bhana 13Wendy Costello 14Rebecca Grainger 15Jonathan S Hausmann 16 17Jean W Liew 12Emily Sirotich 18 19Paul Sufka 20Zachary S Wallace 17 21Jinoos Yazdany # 1Pedro M Machado # 22 23 24Philip C Robinson # 25 26COVID-19 Global Rheumatology Alliance

51

Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry

ACR Open Rheumatol. 2021 Mar;3(3):173-184. doi: 10.1002/acr2.11232. Epub 2021 Feb 11.

Joel M Kremer 1Clifton O Bingham 3rd 2Laura C Cappelli 2Jeffrey D Greenberg 3Ann M Madsen 4Jamie Geier 4Jose L Rivas 5Alina M Onofrei 6Christine J Barr 6Dimitrios A Pappas 7Heather J Litman 6Kimberly J Dandreo 6Andrea B Shapiro 8Carol A Connell 9Arthur Kavanaugh 10

52

The Online Sharing of Instagram Images for Rheumatoid Arthritis

Comput Inform Nurs. 2020 Jul 24;39(2):89-96. doi: 10.1097/CIN.0000000000000660.

Deborah Lewis 1Janice LongNancy MossEileen R Fowles

53

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review

J Clin Med. 2021 Feb 1;10(3):509. doi: 10.3390/jcm10030509.

Peter C Taylor 1Fabiola Atzeni 2Alejandro Balsa 3Laure Gossec 4 5Ulf Müller-Ladner 6Janet Pope 7

54

Peripheral Ulcerative Keratitis in Rheumatoid Arthritis Patients Taking Tocilizumab: Paradoxical Manifestation or Insufficient Efficacy?

Rheumatology (Oxford). 2021 Feb 2;keab093. doi: 10.1093/rheumatology/keab093.Online ahead of print.

Florian Cohen 1Eric Ernest Gabison 2Sophie Stéphan 2Rakiba Belkhir 3Gaetane Nocturne 3 4Anne-Laurence Best 1Oscar Haigh 4Emmanuel Barreau 1Marc Labetoulle 1 4Raphaele Seror 3Antoine Rousseau 1 4

55

Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program

Drug Saf. 2021 Feb 2. doi: 10.1007/s40264-020-01036-w. Online ahead of print.

Philip G Conaghan 1Eduardo Mysler 2Yoshiya Tanaka 3Barbara Da Silva-Tillmann 4Tim Shaw 5John Liu 4Ryan Ferguson 4Jeffrey V Enejosa 4Stanley Cohen 6Peter Nash 7William Rigby 8Gerd Burmester 9

56

Location, location, location: how the tissue microenvironment affects inflammation in RA

Nat Rev Rheumatol. 2021 Feb 1. doi: 10.1038/s41584-020-00570-2.Online ahead of print.

Christopher D Buckley 1 2Caroline Ospelt 3Steffen Gay 3Kim S Midwood 4

57

Safety and Efficacy of Filgotinib: Up to 4-Year Results From an Open-Label Extension Study of Phase 2 Rheumatoid Arthritis Programs

J Rheumatol. 2021 Feb 1;jrheum.201183. doi: 10.3899/jrheum.201183. Online ahead of print.

Arthur Kavanaugh 1Rene R Westhovens 1Kevin L Winthrop 1Susan J Lee 1YingMeei Tan 1Di An 1Lei Ye 1John S Sundy 1Robin Besuyen 1Luc Meuleners 1Mykola Stanislavchuk 1Alberto J Spindler 1Maria Greenwald 1Rieke Alten 1Mark C Genovese 1

 

58

Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

Rheumatol Ther. 2021 Jan 23. doi: 10.1007/s40744-020-00275-8. Online ahead of print.

Alison Walton 1Jim Paik 2Amanda Quebe 2Carol L Kannowski 2Casey Choong 2Seth Anderson 2Justin K Owensby 3

59

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Lancet. 2021 Jan 23;397(10271):305-317.doi: 10.1016/S0140-6736(20)32341-2.

Frances Humby 1Patrick Durez 2Maya H Buch 3Myles J Lewis 1Hasan Rizvi 4Felice Rivellese 1Alessandra Nerviani 1Giovanni Giorli 5Arti Mahto 6Carlomaurizio Montecucco 7Bernard Lauwerys 2Nora Ng 8Pauline Ho 9Michele Bombardieri 1Vasco C Romão 10Patrick Verschueren 11Stephen Kelly 12Pier Paolo Sainaghi 13Nagui Gendi 14Bhaskar Dasgupta 15Alberto Cauli 16Piero Reynolds 17Juan D Cañete 18Robert Moots 19Peter C Taylor 20Christopher J Edwards 21John Isaacs 22Peter Sasieni 23Ernest Choy 24Costantino Pitzalis 25R4RA collaborative group

60

Corticosteroids: Review of the History, the Effectiveness, and Adverse Effects in the Treatment of Joint Pain

Pain Physician. 2021 Jan;24(S1):S233-S246.

Shane Stone 1Gerard A Malanga 2Teresa Capella 3

61

Pain and fatigue are longitudinally and bi-directionally associated with more sedentary time and less standing time in rheumatoid arthritis

Rheumatology (Oxford). 2021 Jan 25;keab029. doi: 10.1093/rheumatology/keab029.Online ahead of print.

Ciara M O'Brien 1 2Nikos Ntoumanis 3Joan L Duda 1George D Kitas 2Jet J C S Veldhuijzen van Zanten 1 2George S Metsios 2 4Sally A M Fenton 1 2

62

Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review

Rheumatol Int. 2021 Jan 29. doi: 10.1007/s00296-020-04773-4. Online ahead of print.

Julie K Dawson 1Edmond Quah 2Ben Earnshaw 2Constanta Amoasii 2Tareg Mudawi 2Lisa G Spencer 3

63

Erectile Dysfunction and Cardiovascular Risk in Men with Rheumatoid Arthritis: A Population- Based Cohort Study

J Rheumatol. 2021 Jan 15;jrheum.201226. doi: 10.3899/jrheum.201226. Online ahead of print.

Katelynn M Wilton 1Sara J Achenbach 1John M Davis 3rd 1Elena Myasoedova 1Eric L Matteson 1Cynthia S Crowson 1

64

Development of a Patient-centered Quality Measurement Framework for Measuring, Monitoring, and Optimizing Rheumatoid Arthritis Care in Canada

J Rheumatol. 2020 Sep 1;jrheum.200688. doi: 10.3899/jrheum.200688. Online ahead of print.

Claire E H Barber 1Karen L Then 1Victoria Bohm 1Marc Hall 1Deborah A Marshall 1James A Rankin 1Cheryl Barnabe 1Glen S Hazlewood 1Linda C Li 1Dianne Mosher 1Joanne Homik 1Paul MacMullan 1Karen Tsui 1Kelly English 1Diane LacailleRA Quality Measurement Delphi Panel Group

65

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

Ann Rheum Dis. 2021 Jan 15;annrheumdis-2020-219213.doi: 10.1136/annrheumdis-2020-219213. Online ahead of print.

René Westhovens 1 2William F C Rigby 3Désirée van der Heijde 4Daniel W T Ching 5William Stohl 6Jonathan Kay 7 8Arvind Chopra 9Beatrix Bartok 10Franziska Matzkies 10Zhaoyu Yin 10Ying Guo 10Chantal Tasset 11John S Sundy 10 12Angelika Jahreis 10Neelufar Mozaffarian 13Osvaldo Daniel Messina 14 15Robert Bm Landewé 16 17Tatsuya Atsumi 18Gerd R Burmester 19 20

66

Is gene expression among women with rheumatoid arthritis dysregulated during a postpartum flare?

Arthritis Res Ther. 2021 Jan 18;23(1):30. doi: 10.1186/s13075-021-02418-w.

Matthew Wright 1Mette K Smed 2J Lee Nelson 3 4Jørn Olsen 5 6Merete L Hetland 7 8Vibeke Zoffmann 2 9Damini Jawaheer 10 11

67

Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients

Rheumatology (Oxford). 2021 Jan 18;keaa836. doi: 10.1093/rheumatology/keaa836.Online ahead of print.

Jeffrey A Sparks 1 2Yinzhu Jin 3Soo-Kyung Cho 4Seanna Vine 3Rishi Desai 2 3Tracy J Doyle 2 5Seoyoung C Kim 1 2 3

68

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab

Biologics. 2021 Jan 6;15:1-15. doi: 10.2147/BTT.S285610. eCollection 2021.

Timothy Fitzgerald 1Richard Melsheimer 2Marie-Hélène Lafeuille 3Patrick Lefebvre 3Laura Morrison 3Kimberly Woodruff 1Iris Lin 1Bruno Emond 3

69

Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis

Rheumatology (Oxford). 2021 Jan 12;keaa834. doi: 10.1093/rheumatology/keaa834.Online ahead of print.

Andrew R Melville 1 2Md Yuzaiful Md Yusof 1 2John Fitton 1 2Leticia Garcia-Montoya 1 2Lynda Bailey 3Shouvik Dass 1 2Paul Emery 1 2Maya H Buch 1 4Benazir Saleem 3

70

Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data

Arthritis Res Ther. 2021 Jan 11;23(1):17. doi: 10.1186/s13075-020-02399-2.

Teresa A Simon 1 2Lixian Dong 3Kevin L Winthrop 4

71

Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis

BMC Musculoskelet Disord. 2021 Jan 8;22(1):47. doi: 10.1186/s12891-020-03917-8.

Alison Hammond 1Yeliz Prior 2Sarah Cotterill 3Chris Sutton 3Elizabeth Camacho 4Calvin Heal 3Jo Adams 5Yvonne Hough 6Terence W O'Neill 7 8Jill Firth 9

72

Thoracic Manifestations of Rheumatoid Arthritis

Radiographics. Jan-Feb 2021;41(1):32-55. doi: 10.1148/rg.2021200091.

Lauren K Groner 1Daniel B Green 1Stacey V Weisman 1Alan C Legasto 1Dennis Toy 1James F Gruden 1Joanna G Escalon 1

73

Current Management of Trigger Digit in Rheumatoid Arthritis Patients: A Survey of ASSH Members

Hand (N Y). 2020 Dec 29;1558944720975137. doi: 10.1177/1558944720975137.Online ahead of print.

Rebecca Bickham 1, Logan Carr 2, James Butterfield 1, Brittany Behar 3, Ann-Marie Dyer 1, Alexander Payatakes 1

74

Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses

BMJ Open. 2020 Dec 31;10(12):e041420. doi: 10.1136/bmjopen-2020-041420.

Carlos Alves 1 2, Ana Penedones 2, Diogo Mendes 2, Francisco Batel-Marques 3 2

75

Statins and lower mortality in rheumatic diseases: An effect of immortal time bias?

Semin Arthritis Rheum. 2020 Dec 19;51(1):211-218.doi: 10.1016/j.semarthrit.2020.11.010. Online ahead of print.

Devin Abrahami 1, Marie Hudson 2, Samy Suissa 3

76

C-reactive protein and implications in rheumatoid arthritis and associated comorbidities

Semin Arthritis Rheum. 2020 Dec 17;51(1):219-229.doi: 10.1016/j.semarthrit.2020.11.005. Online ahead of print.

Janet E Pope 1, Ernest H Choy 2

77

The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT

Rheumatol Int. 2021 Jan 2. doi: 10.1007/s00296-020-04760-9. Online ahead of print.

Sean G McKenna 1 2, Alan Donnelly 3 4, Bente Appel Esbensen 5 6, Laura Comber 7, Wan Lin Ng 8, Aqeel Maqsoon Anjum 8, Alexander Fraser 8, Norelee M Kennedy 7 4

78

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study

Rheumatology (Oxford). 2020 Dec 25;keaa771. doi: 10.1093/rheumatology/keaa771.Online ahead of print.

Jennifer C E Lane 1, James Weaver 2, Kristin Kostka 3, Talita Duarte-Salles 4, Maria Tereza F Abrahao 5, Heba Alghoul 6, Osaid Alser 7, Thamir M Alshammari 8, Carlos Areia 9, Patricia Biedermann 10, Juan M Banda 11, Edward Burn 1 4, Paula Casajust 12, Kristina Fister 13, Jill Hardin 2, Laura Hester 2, George Hripcsak 14 15, Benjamin Skov Kaas-Hansen 16 17, Sajan Khosla 18, Spyros Kolovos 1, Kristine E Lynch 19 20, Rupa Makadia 2, Paras P Mehta 21, Daniel R Morales 22, Henry Morgan-Stewart 3, Mees Mosseveld 23, Danielle Newby 24, Fredrik Nyberg 25, Anna Ostropolets 14, Rae Woong Park 26, Albert Prats-Uribe 1, Gowtham A Rao 2, Christian Reich 3, Peter Rijnbeek 23, Anthony G Sena 2 23, Azza Shoaibi 2, Matthew Spotnitz 14, Subbian Vignesh 27, Marc A Suchard 28, David Vizcaya 29, Haini Wen 30, Marcel de Wilde 23, Junqing Xie 1, Seng Chan You 26, Lin Zhang 31 32, Simon Lovestone 33, Patrick Ryan 2 14, Daniel Prieto-Alhambra 1, OHDSI-COVID-19 consortium

79

Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis

Int Immunopharmacol. 2020 Dec 23;91:107260. doi: 10.1016/j.intimp.2020.107260.Online ahead of print.

Alison D Petro 1, Joseph Dougherty 2, Bryant R England 3, Harlan Sayles 4, Michael J Duryee 5, Carlos D Hunter 6, Joel M Kremer 7, Dimitrios A Pappas 8, William H Robinson 9, Jeffrey R Curtis 10, Geoffrey M Thiele 11, Ted R Mikuls 12

80

The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis

Semin Arthritis Rheum. 2020 Dec 17;51(1):15-19.doi: 10.1016/j.semarthrit.2020.09.016. Online ahead of print.

Doyt L Conn 1

81

Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease

Rheumatology (Oxford). 2020 Dec 17;keaa860. doi: 10.1093/rheumatology/keaa860.Online ahead of print.

Nadia M T Roodenrijs 1, Marlies C van der Goes 1 2, Paco M J Welsing 1, Janneke Tekstra 1, Floris P J G Lafeber 1, Johannes W G Jacobs 1, Jacob M van Laar 1

82

Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway

Rheumatology (Oxford)2020 Dec 17;keaa858. doi: 10.1093/rheumatology/keaa858.Online ahead of print.

John Fitton 1 2, Andrew R Melville 1 2, Paul Emery 1 2, Jacqueline L Nam 1 2, Maya H Buch 1 3

83

Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience

Clin Exp Rheumatol. 2020 Dec 18. Online ahead of print.

Francesca Romana Spinelli 1, Fulvia Ceccarelli 2, Cristina Garufi 2, Ilaria Duca 2, Silvia Mancuso 2, Enrica Cipriano 2, Elisabetta Dell'Unto 2, Cristiano Alessandri 2, Manuela Di Franco 2, Carlo Perricone 3, Roberta Priori 2, Valeria Riccieri 2, Rossana Scrivo 2, Antonio Sili Scavalli 2, Simona Truglia 2, Guido Valesini 2, Fabrizio Conti 2

84

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons

Front Med (Lausanne). 2020 Nov 23;7:601618. doi: 10.3389/fmed.2020.601618.eCollection 2020.

Irene Llorente 1, Noelia García-Castañeda 1, Cristina Valero 1, Isidoro González-Álvaro 1, Santos Castañeda 1 2

85

Rheumatoid arthritis medication adherence in a health system specialty pharmacy

Am J Manag Care. 2020 Dec 1;26(12):e380-e387. doi: 10.37765/ajmc.2020.88544.

Nate Berger 1, Megan Peter, Josh DeClercq, Leena Choi, Autumn D Zuckerman

86

Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY

Rheumatology (Oxford). 2020 Dec 11;keaa770. doi: 10.1093/rheumatology/keaa770.Online ahead of print.

Vibeke Strand 1, Namita Tundia 2, Alvin Wells 3, Maya H Buch 4 5, Sebastiao C Radominski 6, Heidi S Camp 7, Alan Friedman 7, Jessica L Suboticki 8, Kendall Dunlap 8, Debbie Goldschmidt 9, Martin Bergman 10

87

Efficacy, Safety, and Immunogenicity of Biosimilar Etanercept (Enerceptan) Versus Its Original Form in Combination With Methotrexate in Patients With Rheumatoid Arthritis: A Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study

J Clin Rheumatol. 2020 Dec 14;Publish Ahead of Print doi:10.1097/RHU.0000000000001616.Online ahead of print.

Ingrid Strusberg 1, Eduardo Mysler, Gustavo Citera, Daniel Siri, Maria de Los Ángeles Correa, Maria Alicia Lazaro, Rodolfo Pardo Hidalgo, Alberto Spindler, Patricio Tate, Horacio Venarotti, Jorge Velasco Zamora, Ezequiel Klimovsky, Andrea Federico, Eduardo Scheines, Eliseo Gonzalez, Lucas Cordeiro, Nestor Lago

88

Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis

Rheumatology (Oxford). 2020 Dec 9;keaa557. doi: 10.1093/rheumatology/keaa557.Online ahead of print.

Konstantinos Thomas, Argyro Lazarini 1, Evripidis Kaltsonoudis 2, Paraskevi V Voulgari 2, Alexandros A Drosos 2, Argyro Repa 3, Ainour Molla Ismail Sali 3, Prodromos Sidiropoulos 3, Panagiota Tsatsani 4, Sousana Gazi 4, Argyriou Evangelia 5, Kyriaki A Boki 5, Pelagia Katsimbri 1, Dimitrios Boumpas 1, Kalliopi Fragkiadaki 1, Maria G Tektonidou 1, Petros P Sfikakis 1, Konstantina Karagianni 6, Lazaros I Sakkas 6, Eleftheria P Grika 1, Panagiotis G Vlachoyiannopoulos 1, Gerasimos Evangelatos 7, Alexios Iliopoulos 7, Theodoros Dimitroulas 8, Alexandros Garyfallos 8, Konstantinos Melissaropoulos 9, Panagiotis Georgiou 9, Maria Areti 10, Constantinos Georganas 11, Periklis Vounotrypidis 12, Georgios Georgiopoulos 1, George D Kitas 1 13, Dimitrios Vassilopoulos 1

89

Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis

Nat Rev Rheumatol. 2020 Dec 8. doi: 10.1038/s41584-020-00541-7.Online ahead of print.

Maya H Buch 1 2 3, Stephen Eyre 4 5, Dennis McGonagle 6 7

90

Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19

Rheumatol Int.2020 Nov 30;1-10. doi: 10.1007/s00296-020-04751-w. Online ahead of print.

Sophia M Brady 1 2 3, Sally A M Fenton 1 2 3, George S Metsios 2 4, Ailsa Bosworth 5, Joan L Duda 1 3, George D Kitas 1 2, Jet J C S Veldhuijzen van Zanten 6 7 8

91

Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients

Arthritis Res Ther. 2020 Dec 4;22(1):282. doi: 10.1186/s13075-020-02355-0.

Jeffrey R Curtis 1, Fenglong Xie 2, Cynthia S Crowson 3, Eric H Sasso 4 5, Elena Hitraya 4 5, Cheryl L Chin 4 5, Richard D Bamford 4 5, Rotem Ben-Shachar 5, Alexander Gutin 5, Darl D Flake 2nd 5, Brent Mabey 5, Jerry S Lanchbury 5

92

A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis

Rheumatol Ther. 2020 Nov 26. doi: 10.1007/s40744-020-00257-w. Online ahead of print.

Christopher J Edwards 1Ruta Sawant 2Vishvas Garg 2Ella X Du 3Alan Friedman 2Keith A Betts 4

93

Update on the diagnosis and management of early rheumatoid arthritis

Clin Med (Lond). 2020 Nov;20(6):561-564. doi: 10.7861/clinmed.2020-0727.

Peter C Taylor 1

94

Rheumatoid arthritis and bone health

Clin Med (Lond). 2020 Nov;20(6):565-567. doi: 10.7861/clinmed.20.6.rabh.

Shanze Ashai 1Nicholas C Harvey 2

95

Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study

Rheumatology (Oxford). 2020 Nov 17;keaa576. doi: 10.1093/rheumatology/keaa576.Online ahead of print.

Josef S Smolen 1Li Xie 2Bochao Jia 2Peter C Taylor 3Gerd Burmester 4Yoshiya Tanaka 5Ayesha Elias 2Anabela Cardoso 2Rob Ortmann 2Chad Walls 2Maxime Dougados 6

96

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission on Combination Therapy: A Randomized, Double-Blind Trial

Arthritis Rheumatol. 2020 Nov 18. doi: 10.1002/art.41589. Online ahead of print.

Jeffrey R Curtis 1Paul Emery 2Elaine Karis 3Boulos Haraoui 4Vivian Bykerk 5Priscilla K Yen 3Greg Kricorian 3James B Chung 3

97

Joint Destruction Is Associated With All Types of Cardiovascular Events in French Rheumatoid Patients: A Real-Life Study With Very Long Follow-Up

Front Med (Lausanne). 2020 Oct 30;7:556086. doi: 10.3389/fmed.2020.556086.eCollection 2020.

Marie Robert 1Arnaud Hot 2François Mifsud 1Ndiémé Ndongo-Thiam 1Pierre Miossec 1

98

Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis

Ann Rheum Dis. 2020 Nov 4;annrheumdis-2020-218412.doi: 10.1136/annrheumdis-2020-218412. Online ahead of print.

Roy M Fleischmann 1, Ricardo Blanco 2, Stephen Hall 3, Glen T D Thomson 4, Filip E Van den Bosch 5 6, Cristiano Zerbini 7, Louis Bessette 8 9, Jeffrey Enejosa 10, Yihan Li 10, Yanna Song 10, Ryan DeMasi 10, In-Ho Song 10

99

The Role of the Microbiome in Driving RA-Related Autoimmunity

Front Cell Dev Biol. 2020 Sep 29;8:538130. doi: 10.3389/fcell.2020.538130.eCollection 2020.

Cristopher M Rooney 1, Kulveer Mankia 1 2, Paul Emery 1 2

100

The patient perspective of nurse-led care in early rheumatoid arthritis: A systematic review of qualitative studies with thematic analysis

J Clin Nurs. 2020 Oct 30. doi: 10.1111/jocn.15531. Online ahead of print.

Anne-Marie Tetsche Sweeney 1 2, Candy McCabe 1 3 4, Caroline A Flurey 5, Joanna C Robson 1 2, Alice Berry 1 2, Pamela Richards 1 2, Mwidimi Ndosi 1 2

101

Factors associated with disability in patients with rheumatoid arthritis with persistent moderate disease activity: a retrospective cohort study

BMC Rheumatol. 2020 Oct 21;4:63. doi: 10.1186/s41927-020-00161-4. eCollection 2020.

Ian C Scott 1 2, Julie Mount 3, Jane Barry 3, Bruce Kirkham 4

102

Multimorbidity and Fatigue in Rheumatoid Arthritis: A Cross-Sectional Study of a Population-Based Cohort

Rheumatol Ther. 2020 Oct 28. doi: 10.1007/s40744-020-00247-y. Online ahead of print.

John M Davis 3rd 1, Elena Myasoedova 2, Tina M Gunderson 3, Cynthia S Crowson 2 3

103

Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme

Ann Rheum Dis. 2020 Oct 28;annrheumdis-2020-218510.doi: 10.1136/annrheumdis-2020-218510. Online ahead of print.

Stanley B Cohen 1, Ronald F van Vollenhoven 2, Kevin L Winthrop 3, Cristiano A F Zerbini 4, Yoshiya Tanaka 5, Louis Bessette 6, Ying Zhang 7, Nasser Khan 7, Barbara Hendrickson 7, Jeffrey V Enejosa 7, Gerd R Burmester 8

104

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

RMD Open. 2020 Oct;6(3):e001395. doi: 10.1136/rmdopen-2020-001395.

Stanley B Cohen 1, Yoshiya Tanaka 2, Xavier Mariette 3, Jeffrey R Curtis 4, Eun Bong Lee 5, Peter Nash 6, Kevin L Winthrop 7, Christina Charles-Schoeman 8, Lisy Wang 9, Connie Chen 10, Kenneth Kwok 10, Pinaki Biswas 10, Andrea Shapiro 11, Ann Madsen 10, Jürgen Wollenhaupt 12

105

Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions

Peter Hanlon 1, Elaine Butterly 1, Jim Lewsey 1, Stefan Siebert 2, Frances S Mair 1, David A McAllister 3

106

Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib

Arthritis Res Ther. 2020 Oct 15;22(1):243. doi: 10.1186/s13075-020-02324-7.

Vibeke Strand 1, Jeffrey Kaine 2, Rieke Alten 3, Gene Wallenstein 4, Annette Diehl 5, Harry Shi 5, Rebecca Germino 6, Christopher W Murray 7

107

Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available

Arthritis Res Ther. 2020 Oct 15;22(1):242. doi: 10.1186/s13075-020-02310-z.

Jeffrey R Curtis 1 2 3, Fenglong Xie 4, Hong Zhou 4, David Salchert 4, Huifeng Yun 4 5

108

Long-term Glucocorticoid Use in Rheumatoid Arthritis

J Rheumatol. 2020 Oct 15;jrheum.201137. doi: 10.3899/jrheum.201137. Online ahead of print.

Maarten Boers 1, Theodore Pincus 1

109

10-year follow-up of patients with rheumatoid arthritis and secondary Sjögren

Clin Exp Rheumatol. 2020 Sep 23. Online ahead of print.

Rada V Moerman 1, Suzanne Arends 1, Esther Mossel 1, Frans G M Kroese 1, Arjan Vissink 2, Hendrika Bootsma 3

110

Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis

Adv Ther. 2020 Oct 9. doi: 10.1007/s12325-020-01501-z. Online ahead of print.

Stanley B Cohen 1, Jeffrey D Greenberg 2, James Harnett 3, Ann Madsen 4, Timothy W Smith 4, David Gruben 5, Richard Zhang 4, Tatjana Lukic 4, John Woolcott 6, Kimberly J Dandreo 2, Heather J Litman 2, Taylor Blachley 2, Anne Lenihan 7, Connie Chen 4, Jose L Rivas 8, Maxime Dougados 9 10

111

Implementation and Evaluation of Audit and Feedback for Monitoring Treat-to-Target (T2T) Strategies in Rheumatoid Arthritis Using Performance Measures

Rheumatol Ther. 2020 Oct 9. doi: 10.1007/s40744-020-00237-0. Online ahead of print.

Claire E H Barber 1 2 3, Dianne Mosher 4, Shawn Dowling 4, Victoria Bohm 4, Nathan M Solbak 4, Paul MacMullan 4, Bo Pan 5, Cheryl Barnabe 4 6 7, Glen S Hazlewood 4 6 7, Karen L Then 8, Deborah A Marshall 4 6 7, James A Rankin 8, Linda C Li 7 9, Karen Tsui 10, Kelly English 10, Joanne Homik 11, Nicole Spencer 4, Marc Hall 8, Diane Lacaille 7 12

112

Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis

Clin Rheumatol. 2020 Oct 11. doi: 10.1007/s10067-020-05402-y. Online ahead of print.

Hilde Berner Hammer 1 2, Brigitte Michelsen 3 4, Joe Sexton 3, Till Uhlig 3 5, Sella A Provan 3

113

EULAR recommendations for a core data set for pregnancy registries in rheumatology

Ann Rheum Dis. 2020 Oct 14;annrheumdis-2020-218356.doi: 10.1136/annrheumdis-2020-218356. Online ahead of print.

Yvette Meissner 1, Rebecca Fischer-Betz 2, Laura Andreoli 3 4, Nathalie Costedoat-Chalumeau 5 6, Diederik De Cock 7, Radboud J E M Dolhain 8, Frauke Forger 9, Doreen Goll 10, Anna Molto 11 12, Catherine Nelson-Piercy 13 14, Rebecca Özdemir 15, Luigi Raio 16, Sebastian Cruz Rodríguez-García 17, Savino Sciascia 18, Marianne Wallenius 19 20, Astrid Zbinden 9, Angela Zink 21, Anja Strangfeld 21

114

Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women

Arthritis Care Res (Hoboken). 2020 Oct 1. doi: 10.1002/acr.24471. Online ahead of print.

Jeffrey R Curtis 1, Michael Weinblatt 2, Kenneth Saag 1, Vivian P Bykerk 3, Daniel E Furst 4 5 6, Stefano Fiore 7, Gregory St John 8, Toshio Kimura 8, Shen Zheng 7, Clifton O Bingham 3rd 9, Grace Wright 10, Martin Bergman 11, Kamala Nola 12, Christina Charles-Schoeman 4, Nancy Shadick 2

115

Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials

Nutrients. 2020 Sep 29;12(10):E2991. doi: 10.3390/nu12102991.

Josefine Nelson 1, Helen Sjöblom 2, Inger Gjertsson 3, Stine M Ulven 4, Helen M Lindqvist 5, Linnea Bärebring 5

116

Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study

J Rheumatol. 2020 Oct 1;jrheum.191252. doi: 10.3899/jrheum.191252. Online ahead of print.

Anat Fisher 1, Marie Hudson 1, Robert W Platt 1, Colin R Dormuth, Canadian Network for Observational Drug Effect Studies (CNODES) Investigators

117

24-hour Activity and Sleep Profiles for Adults Living with Arthritis: Habits Matter

Arthritis Care Res (Hoboken). 2020 Oct 6. doi: 10.1002/acr.24424. Online ahead of print.

Lynne M Feehan 1, Na Lu 2, Hui Xie 2, Linda C Li 1

118

Weight Fluctuation and the Risk of Cardiovascular Events in Patients with Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2020 Oct 1. doi: 10.1002/acr.24469. Online ahead of print.

Joshua F Baker 1 2 3, George Reed 4 5, Joel Kremer 6 7

119

Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study

Lancet Rheumatol. 2020 Sep 21. doi: 10.1016/S2665-9913(20)30305-2. Online ahead of print.

Chris A Gentry 1, Mary Beth Humphrey 2 3, Sharanjeet K Thind 4 5, Sage C Hendrickson 1, George Kurdgelashvili 4 5, Riley J Williams 2nd 1

120

Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry

ACR Open Rheumatol. 2020 Sep 29.doi: 10.1002/acr2.11168. Online ahead of print.

Dimitrios A Pappas 1, Ying Shan 2, Tamara Lesperance 3, Greg Kricorian 4, Elaine Karis 4, Sabrina Rebello 2, Winnie Hua 2, Neil A Accortt 4, Scott Stryker 4

121

Adiposity and the risk of rheumatoid arthritis: a systematic review and meta-analysis of cohort studies

Sci Rep. 2020 Sep 29;10(1):16006. doi: 10.1038/s41598-020-71676-6.

Tomoya Ohno 1 2, Dagfinn Aune 3 4 5, Alicia K Heath 1

122

Incidence and Complication Rates for Total Hip Arthroplasty in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Across Four Decades

Rheumatol Ther. 2020 Sep 30. doi: 10.1007/s40744-020-00238-z.Online ahead of print.

Owen Taylor-Williams 1, Johannes Nossent 2 3, Charles A Inderjeeth 4 5

123

JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data

J Inflamm Res. 2020 Sep 14;13:519-531. doi: 10.2147/JIR.S219586.eCollection 2020.

Robert Harrington # 1, Shamma Ahmad Al Nokhatha # 1, Richard Conway 1

124

A cross-sectional study of sleep and depression in a rheumatoid arthritis population

Clin Rheumatol. 2020 Sep 24. doi: 10.1007/s10067-020-05414-8. Online ahead of print.

Mark Hughes 1, Alan Chalk 2, Poonam Sharma 3, Sandeep Dahiya 3, James Galloway 4

125

Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity

Rheum Dis Clin North Am. 2020 Nov;46(4):685-692. doi: 10.1016/j.rdc.2020.07.005.Epub 2020 Sep 9.

Cheryl Barnabe 1

126

The impact of disease severity and duration on cost, early retirement and ability to work in rheumatoid arthritis in Europe: an economic modelling study

Rheumatol Adv Pract. 2020 Sep 16;4(2):rkaa041. doi: 10.1093/rap/rkaa041. eCollection 2020.

James Galloway 1, Jean-Philippe Capron 2, Francesco De Leonardis 3, Walid Fakhouri 4, Alison Rose 5, Ilias Kouris 6, Tom Burke 5

127

Depression and subsequent risk for incident rheumatoid arthritis among women

Arthritis Care Res (Hoboken). 2020 Sep 16.doi: 10.1002/acr.24441. Online ahead of print.

Jeffrey A Sparks 1 2, Susan Malspeis 1, Jill Hahn 1 2, Jiaqi Wang 1, Andrea L Roberts 3, Laura D Kubzansky 2 3, Karen H Costenbader 1 2

128

Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study

Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-1594. Online ahead of print.

Michael D George 1, Joshua F Baker 2, Kevin Winthrop 3, Jesse Y Hsu 1, Qufei Wu 1, Lang Chen 4, Fenglong Xie 4, Huifeng Yun 4, Jeffrey R Curtis 4

129

Positive Psychological Factors and Impairment in Rheumatic and Musculoskeletal Disease: Do Psychopathology and Sleep Quality Explain the Linkage?

Arthritis Care Res (Hoboken). 2020 Sep 16. doi: 10.1002/acr.24440. Online ahead of print.

Jameson K Hirsch 1, Heather R Altier 1, Martin Offenbächer 2, Loren Toussaint 3, Niko Kohls 4, Fuschia M Sirois 5

130

Attainment of the Patient-acceptable Symptom State in 548 patients with rheumatoid arthritis: influence of demographic factors

Joint Bone Spine. 2020 Sep 10;S1297-319X(20)30156-1. doi: 10.1016/j.jbspin.2020.09.003.Online ahead of print.

Catia Duarte 1, Eduardo Santos 2, Tore K Kvien 3, Maxime Dougados 4, Maarten de Wit 5, Laure Gossec 6, J A P da Silva 7

131

Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis

ACR Open Rheumatol. 2020 Sep 13. doi: 10.1002/acr2.11175. Online ahead of print.

Luke W Desilet 1, Bryant R England 1, Kaleb Michaud 2, Jennifer L Barton 3, Ted R Mikuls 1, Joshua F Baker 4

132

The clinical effectiveness of intensive management in moderate established rheumatoid arthritis: The titrate trial

Semin Arthritis Rheum. 2020 Jul 30;50(5):1182-1190. doi: 10.1016/j.semarthrit.2020.07.014.Online ahead of print.

David Scott 1, Fowzia Ibrahim 2, Harry Hill 3, Brian Tom 4, Louise Prothero 1, Rhiannon R Baggott 1, Ailsa Bosworth 5, James B Galloway 1, Sofia Georgopoulou 1, Naomi Martin 1, Isabel Neatrour 1, Elena Nikiphorou 1, Jackie Sturt 6, Allan Wailoo 3, Frances Mk Williams 7, Ruth Williams 1, Heidi Lempp 1

133

Reliability and Change in Erosion Measurements by High-Resolution peripheral Quantitative Computed Tomography in a Longitudinal Dataset of Rheumatoid Arthritis Patients

J Rheumatol. 2020 Sep 15;jrheum.191391. doi: 10.3899/jrheum.191391. Online ahead of print.

Stephanie Finzel 1, Sarah L Manske 1, Cheryl Barnabe 1, Andrew J Burghardt 1, Hubert Marotte 1, Andrea Scharmga 1, Ellen-Margrethe Hauge 1, Roland Chapurlat 1, Klaus Engelke 1, Xiaojuan Li 1, Bente van Teeffelen 1, Philip G Conaghan 1, Kathryn S Stok 1

134

Assessment of Placebo Response in Objective and Subjective Outcome Measures in Rheumatoid Arthritis Clinical Trials

JAMA Netw Open. 2020 Sep 1;3(9):e2013196. doi: 10.1001/jamanetworkopen.2020.13196.

Jan Vollert 1 2, Nancy R Cook 1, Ted J Kaptchuk 3, Shiv T Sehra 4, Deirdre K Tobias 1, Kathryn T Hall 1

135

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

Lancet Rheumatol. 2020 Aug 21. doi: 10.1016/S2665-9913(20)30276-9. Online ahead of print.

Jennifer C E Lane 1, James Weaver 2, Kristin Kostka 3, Talita Duarte-Salles 4, Maria Tereza F Abrahao 5, Heba Alghoul 6, Osaid Alser 7, Thamir M Alshammari 8, Patricia Biedermann 9, Juan M Banda 10, Edward Burn 1 4, Paula Casajust 11, Mitchell M Conover 2, Aedin C Culhane 12, Alexander Davydov 13, Scott L DuVall 14 15, Dmitry Dymshyts 13, Sergio Fernandez-Bertolin 4, Kristina Fišter 16, Jill Hardin 2, Laura Hester 2, George Hripcsak 17 18, Benjamin Skov Kaas-Hansen 19 20, Seamus Kent 21, Sajan Khosla 22, Spyros Kolovos 1, Christophe G Lambert 23, Johan van der Lei 24, Kristine E Lynch 14 15, Rupa Makadia 2, Andrea V Margulis 25, Michael E Matheny 26 27, Paras Mehta 28, Daniel R Morales 29, Henry Morgan-Stewart 3, Mees Mosseveld 24, Danielle Newby 30, Fredrik Nyberg 31, Anna Ostropolets 17, Rae Woong Park 32, Albert Prats-Uribe 1, Gowtham A Rao 2, Christian Reich 3, Jenna Reps 2, Peter Rijnbeek 24, Selva Muthu Kumaran Sathappan 33, Martijn Schuemie 2, Sarah Seager 3, Anthony G Sena 2 24, Azza Shoaibi 2, Matthew Spotnitz 17, Marc A Suchard 34, Carmen O Torre 3, David Vizcaya 35, Haini Wen 36, Marcel de Wilde 24, Junqing Xie 1, Seng Chan You 32, Lin Zhang 37 38, Oleg Zhuk 13, </

136

Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review

ACR Open Rheumatol. 2020 Sep 1. doi: 10.1002/acr2.11170. Online ahead of print.

Christina M Daniel 1, Lesley Davila 1, Una E Makris 2, Helen Mayo 3, Liron Caplan 4, Lisa Davis 5, E Blair Solow 1

137

Efficacy predictors of a second tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis

Medicine (Baltimore). 2020 Aug 28;99(35):e21827. doi: 10.1097/MD.0000000000021827.

Jennifer Reams 1, Andrea Berger, Alfred Denio

138

Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis

Ann Rheum Dis. 2020 Aug 28;annrheumdis-2020-217653.doi: 10.1136/annrheumdis-2020-217653. Online ahead of print.

Sven Plein 1, Bara Erhayiem 1, Graham Fent 1, Sarah Horton 2, Raluca Bianca Dumitru 3, Jacqueline Andrews 3, John P Greenwood 1, Paul Emery 3 4

139

Certain perspectives about the use of corticosteroids for managing hospitalized patients with rheumatic diseases

Clin Rheumatol. 2020 Aug 24. doi: 10.1007/s10067-020-05349-0.Online ahead of print.

Sky Wang 1, Richard S Panush 2

140

Complementary and Alternative Medicine Use in Rheumatoid Arthritis

Curr Rheumatol Rep. 2020 Aug 26;22(10):61. doi: 10.1007/s11926-020-00938-z.

Sara Baig 1, Dana D DiRenzo 2

141

Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation

World J Gastrointest Pathophysiol. 2020 Aug 12;11(5):104-113.doi: 10.4291/wjgp.v11.i5.104.

Simcha Weissman 1, Preetika Sinh 2, Tej I Mehta 3, Rishi K Thaker 4, Abraham Derman 5, Caleb Heiberger 3, Nabeel Qureshi 1, Viralkumar Amrutiya 1, Adam Atoot 1, Maneesh Dave 6, James H Tabibian 7

142

Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype

Rheumatology (Oxford). 2020 Aug 18;keaa330. doi: 10.1093/rheumatology/keaa330.Online ahead of print.

Karin Hellgren 1, Daniela Di Giuseppe 1, Karin E Smedby 1, Christer Sundström 2, Johan Askling 1, Eva Baecklund 3

143

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

Rheumatology (Oxford). 2020 Aug 18;keaa393. doi: 10.1093/rheumatology/keaa393.Online ahead of print.

Delphine S Courvoisier 1, Katarina Chatzidionysiou 2, Denis Mongin 1, Kim Lauper 1 3, Xavier Mariette 4, Jacques Morel 5, Jacques-Eric Gottenberg 6, Sytske Anne Bergstra 7, Manuel Pombo Suarez 8, Catalin Codreanu 9, Tore K Kvien 10, Maria Jose Santos 11, Karel Pavelka 12, Merete L Hetland 13 14, Johan Askling 15, Carl Turesson 16, Satoshi Kubo 17, Yoshiya Tanaka 17, Florenzo Iannone 18, Denis Choquette 19, Dan C Nordström 20, Ziga Rotar 21, Galina Lukina 22, Cem Gabay 1, Ronald Van Vollenhoven 22, Axel Finckh 1

Free article

144

Simple Erosion Narrowing Score of the hands as a predictor of cervical spine subluxation in rheumatoid arthritis

SA J Radiol. 2020 Jul 27;24(1):1876. doi: 10.4102/sajr.v24i1.1876. eCollection 2020.

Eric Gous 1, Mahmood M T M Ally 2, Pieter W A Meyer 3, Farhana E Suleman 1

145

Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis

Rheumatol Ther. 2020 Aug 14. doi: 10.1007/s40744-020-00226-3. Online ahead of print.

Martin J Bergman 1, Alan J Kivitz 2, Dimitrios A Pappas 3 4, Joel M Kremer 5, Lixia Zhang 6, Anna Jeter 6, Johanna B Withers 7

146

Enhancing Patient Understanding of Medication Risks and Benefits

Arthritis Care Res (Hoboken). 2020 Aug 16. doi: 10.1002/acr.24421. Online ahead of print.

Susan J Blalock 1, Elizabeth B Solow 2, Valerie F Reyna 3, Molly Keebler 4, Delesha Carpenter 1, Caprice Hunt 1, Genevieve Hickey 1, Kimberlee O'Neill 1, Jeffrey R Curtis 5, Sandra Bond Chapman 4

147

Identification of heterogenous treatment response trajectories to anti-IL6 receptor treatment in rheumatoid arthritis

Sci Rep. 2020 Aug 18;10(1):13975. doi: 10.1038/s41598-020-70942-x.

J P M Blair 1 2, A-C Bay-Jensen 3, M H Tang 4, P Frederiksen 3, C Bager 4, M Karsdal 3, S Brunak 5

148

Brief Report: Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits

Arthritis Care Res (Hoboken). 2020 Aug 19. doi: 10.1002/acr.24429. Online ahead of print.

Bryant R England 1, Claire E H Barber 2 3, Martin Bergman 4, Veena K Ranganath 5, Lisa G Suter 6, Kaleb Michaud 1 7

149

Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI)

Rheumatology (Oxford). 2020 Aug 13;keaa343. doi: 10.1093/rheumatology/keaa343.Online ahead of print.

Janet E Pope 1, Emmanouil Rampakakis 2, Mohammad Movahedi 3 4, Angela Cesta 3, John S Sampalis 2 5, Claire Bombardier 3 6 7

150

A Serum Protein Signature is associated with Rheumatoid Arthritis development

Arthritis Rheumatol. 2020 Aug 7. doi: 10.1002/art.41483. Online ahead of print.

Liam J O'Neil 1, Victor Spicer 1, Irene Smolik 1, Xiaobo Meng 1, Rishi R Goel 2, Vidyanand Anaparti 1, John Wilkins 1, Hani S El-Gabalawy 1

151

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

Ann Rheum Dis. 2020 Aug 11;annrheumdis-2019-216852.doi: 10.1136/annrheumdis-2019-216852. Online ahead of print.

Kevin L Winthrop 1, Masayoshi Harigai 2, Mark C Genovese 3, Stephen Lindsey 4, Tsutomu Takeuchi 5, Roy Fleischmann 6, John D Bradley 7, Nicole L Byers 7, David L Hyslop 7, Maher Issa 7, Atsushi Nishikawa 8, Terence P Rooney 7, Sarah Witt 7, Christina L Dickson 7, Josef S Smolen 9, Maxime Dougados 10

152

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

Ann Rheum Dis. 2020 Aug 5;annrheumdis-2019-216761.doi: 10.1136/annrheumdis-2019-216761. Online ahead of print.

Philip Mease 1, Christina Charles-Schoeman 2, Stanley Cohen 3, Lara Fallon 4, John Woolcott 5, Huifeng Yun 6, Joel Kremer 7, Jeffrey Greenberg 8, Wendi Malley 8, Alina Onofrei 8, Keith S Kanik 9, Daniela Graham 9, Cunshan Wang 10, Carol Connell 11, Hernan Valdez 12, Manfred Hauben 13 14, Eric Hung 13, Ann Madsen 15, Thomas V Jones 16, Jeffrey R Curtis 17

153

Methotrexate Pulmonary Toxicity: Deep Inspirati

Arthritis Rheumatol. 2020 Jul 27. doi: 10.1002/art.41451. Online ahead of print.

Joel M Kremer 1

154

Vitamin D and early rheumatoid arthritis

BMC Rheumatol. 2020 Jul 27;4:38. doi: 10.1186/s41927-020-00134-7. eCollection 2020.

Stephanie R Harrison 1 2, Gurpreet Jutley 3, Danyang Li 1, Ilfita Sahbudin 3, Andrew Filer 3, Martin Hewison 1 4, Karim Raza 2 3

155

Disease modifying anti-rheumatic drugs, biologics and corticosteroid use in older patients with rheumatoid arthritis over 20 years

J Rheumatol. 2020 Aug 1;jrheum.200310. doi: 10.3899/jrheum.200310. Online ahead of print.

John G Hanly 1, Lynn Lethbridge 1

156

The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis

Curr Rheumatol Rep. 2020 Aug 1;22(9):56. doi: 10.1007/s11926-020-00933-4.

Dilli Poudel 1, Michael D George 1 2, Joshua F Baker 3 4 5 6

157

Rhupus: a systematic literature review

Autoimmun Rev. 2020 Jul 12;102612. doi: 10.1016/j.autrev.2020.102612.Online ahead of print.

Luca Antonini 1, Brigitte Le Mauff 2, Christian Marcelli 3, Achille Aouba 4, Hubert de Boysson 5

158

Abdominal Obesity in Comparison with General Obesity and Risk of Developing Rheumatoid Arthritis in Women

J Rheumatol. 2020 Jul 15;jrheum.200056. doi: 10.3899/jrheum.200056. Online ahead of print.

Nathalie E Marchand 1, Jeffrey A Sparks 1, Sara K Tedeschi 1, Susan Malspeis 1, Karen H Costenbader 1, Elizabeth W Karlson 1, Bing Lu 1

159

COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases

Clin Exp Immunol. 2020 Jul 16. doi: 10.1111/cei.13495. Online ahead of print.

David Baker 1, Charles Ak Roberts 1, Gareth Pryce 1, Angray S Kang 1 2, Monica Marta 1 3, Saul Reyes 1 3, Klaus Schmierer 1 3, Gavin Giovannoni 1 3, Sandra Amor 1 4

160

Promoting engagement in physical activity in early rheumatoid arthritis: A proof-of-concept intervention study

Musculoskeletal Care. 2020 Jul 14. doi: 10.1002/msc.1493. Online ahead of print.

Fiona Cramp 1, Rachel Thomas 1, Anne M Haase 1 2 3, Melissa Domaille 1 4, Sarah Manns 1, Caroline Swales 1 5, Judy Hurfurt 1 5, Nicola E Walsh 1

161

Methotrexate and rheumatoid arthritis associated interstitial lung disease

Eur Respir J. 2020 Jul 9;2000337. doi: 10.1183/13993003.00337-2020. Online ahead of print.

Pierre-Antoine Juge 1 2, Joyce S Lee 3 2, Jessica Lau 4 2, Leticia Kawano-Dourado 5, Jorge Rojas Serrano 6, Marco Sebastiani 7, Gouri Koduri 8, Eric Matteson 9 10, Karina Bonfiglioli 11, Marcio Sawamura 12, Ronaldo Kairalla 5, Lorenzo Cavagna 13, Emanuele Bozzalla Cassione 13, Andreina Manfredi 7, Mayra Mejia 6, Pedro Rodríguez-Henriquez 14, Montserrat I González-Pérez 6, Ramcés Falfán-Valencia 15, Ivette Buendia-Roldán 16, Gloria Pérez-Rubio 15, Esther Ebstein 1, Steven Gazal 17 18, Raphaël Borie 19, Sébastien Ottaviani 1, Caroline Kannengiesser 20, Benoît Wallaert 21, Yurdagul Uzunhan 22, Hilario Nunes 22, Dominique Valeyre 22, Nathalie Saidenberg-Kermanac'h 23, Marie-Christophe Boissier 23, Lidwine Wemeau-Stervinou 21, René-Marc Flipo 24, Sylvain Marchand-Adam 25, Pascal Richette 26 27, Yannick Allanore 28 29, Claire Dromer 30, Marie-Elise Truchetet 31, Christophe Richez 31, Thierry Schaeverbeke 31, Huguette Lioté 32, Gabriel Thabut 33, Kevin D Deane 3, Joshua Solomon 34, Tracy Doyle 35, Jay H Ryu 4, Ivan Rosas 35, V Michael Holers 3, Catherine Boileau 20, Marie-Pierre Debray 36, Raphaël Porcher 37 38, David A Schwartz 3, Robert Vassallo 4, Bruno Crestani 20 2, Philippe Dieudé 39 2

162

Prevalence of Malignancy Among Urban Black Rheumatoid Arthritis Patients

Int J Clin Res Trials. 2020;5(1):145. doi: 10.15344/2456-8007/2020/145. Epub 2020 Apr 25.

Isabel M McFarlane 1, Manjeet S Bhamra 2, Abhimnayu Amarnani 1, Su Yien Zhaz 3, Srinivas Kolla 4, Milena Rodriguez Alvarez 1, George Mo 1, Maya Srinivasan 1, Gil Hevroni 1, Talia Meisel 1, Abida Hasan 1, Marie S Baguidy 1, Michael Hadaddin 1, Adielle Melamed 1, Kristaq Koci 1, Nicholas Taklalsingh 1, Joshy Pathiparampil 1, Latoya Freeman 1, Ian Kaplan 1, Naureen Kabani 1, David J Ozeri 5, Elsie Watler 1, Mosab Frefer 1, Vytas Vaitkus 1, Keron Matthew 1, Fray Arroyo-Mercado 1, Helen Lyo 1, Aleksander Feoktistov 1, Randolph Sanchez 6, Faisal Soliman 7, Felix Reyes Valdez 8, Veena Dronamraju 1, Michael Trevisonno 1, Christon Grant 1, Guerrier Clerger 1, Kunfeng Sun 1, Khabbab Amin 1, Makeda Dawkins 1, Jason Green 1, Samir Fahmy 3, Apoorva Jayarangaiah 9, Stephen Anthony Waite 4, Aaliya Burza 10

163

Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?

Clin Exp Rheumatol. 2020 Jun 30.Online ahead of print.

Frederique Ponchel 1, Myrthe A M van Delft 2, Xuanxiao Xie 3, Agata N Burska 3, Laurence Duquenne 3, Leendert A Trouw 4, Paul Emery 5

164

ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis

Clin Exp Rheumatol. 2020 Jul 10. Online ahead of print.

Christof Specker 1, Annette Alberding 2, Martin Aringer 3, Gerd-Rüdiger Burmester 4, Jan-Paul Flacke 5, Michael W Hofmann 6, Peter Kästner 7, Herbert Kellner 8, Frank Moosig 9, Maren Sieburg 10, Hans-Peter Tony 11, Gerhard Fliedner 12

165

Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions

Int J Mol Sci. 2020 Jun 30;21(13):4645.doi: 10.3390/ijms21134645.

Robert Root-Bernstein 1

166

Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study

LoS One. 2020 Jun 18;15(6):e0234813. doi: 10.1371/journal.pone.0234813. eCollection 2020.

Emma Foster 1 2 3, Michael J Malloy 4 5, Vilija G Jokubaitis 1 2, C David H Wrede 6 7, Helmut Butzkueven 1 2, Joe Sasadeusz 8, Sharon Van Doornum 9 10, Finlay Macrae 11, Gary Unglik 12, Julia M L Brotherton 4 5, Anneke van der Walt 1 2 3

167

Rheumatoid Arthritis: Pathogenesis, Prediction and Prevention - An Emerging Paradigm Shift

Arthritis Rheumatol. 2020 Jun 30. doi: 10.1002/art.41417. Online ahead of print.

Kevin D Deane 1, V Michael Holers 1

168

Disease Modifying Anti-Rheumatic Drugs (DMARD)

Onecia Benjamin 1, Pankaj Bansal 2, Amandeep Goyal 3, Sarah L. Lappin 4

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan.

2020 Jul 4.

169

Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study

Patient Prefer Adherence. 2020 May 18;14:829-838. doi: 10.2147/PPA.S221897.eCollection 2020.

Glen S Hazlewood 1 2 3, Deborah A Marshall 1 2 3, Claire E H Barber 1 2 3, Linda C Li 3, Cheryl Barnabe 1 2 3, Vivian Bykerk 4 5, Peter Tugwell 6, Pauline M Hull 7, Nick Bansback 3 8

170

SB4 in the Era of Biosimilars: Clinical Data and Real-World Experience

Mediterr J Rheumatol. 2019 May 31;30(Suppl 1):59-62. doi: 10.31138/mjr.30.1.59.eCollection 2019 Jun.

Shing T Law 1, Peter C Taylor 1

171

Selection and Perception of Methotrexate Treatment Information in People With Rheumatoid Arthritis

Int J Rheum Dis. 2020 Jun;23(6):805-812. doi: 10.1111/1756-185X.13833. Epub 2020 Jun 14.

Nieves Leonardo 1, Susan Lester 1 2, Michelle Graham 3, Claire Barrett 4 5, Samuel Whittle 1, Debra Rowett 6 7, Rachelle Buchbinder 8 9, Catherine L Hill 1 2

172

Up to 5-year Retention of Abatacept in Belgian Patients With Moderate-To-Severe Rheumatoid Arthritis: A Sub-Analysis of the International, Observational ACTION Study

Rheumatol Int. 2020 Jun 17. doi: 10.1007/s00296-020-04619-z. Online ahead of print.

R Westhovens 1, S E Connolly 2, J Margaux 3, M Vanden Berghe 4, M Maertens 5, M Van den Berghe 6, Y Elbez 7, M Chartier 8, F Baeke 9, S Robert 9, M Malaise 10

173

Lack of Association Between Clinical and Ultrasound Measures of Disease Activity in Rheumatoid Arthritis Remission

Ther Adv Musculoskelet Dis. 2020 May 11;12:1759720X20915322.doi: 10.1177/1759720X20915322. eCollection 2020.

Kenneth F Baker 1, Ben Thompson 1, Dennis W Lendrem 1, Adam Scadeng 2, Arthur G Pratt 1, John D Isaacs 3

174

Prevalence of and Changes in Tooth Loss Among Adults Aged =50 Years With Selected Chronic Conditions - United States, 1999-2004 and 2011-2016

MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):641-646 doi: 10.15585/mmwr.mm6921a1.

Marcia L Parker, Gina Thornton-Evans, Liang Wei, Susan O Griffin

175

Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2020 May 31. doi: 10.1002/acr.24341. Online ahead of print.

Joshua F Baker 1 2 3, Andrew Stokes 4, Sofia Pedro 5, Ted R Mikuls 6, Michael George 2, Bryant R England 6, Harlan Sayles 6, Fred Wolfe 5, Kaleb Michaud 5 6

176

Adaptive Engagement and Support Model for People With Chronic Health Conditions: Using Combined Content Analysis to Assess Online Health Communities

J Med Internet Res. 2020 Jun 3. doi: 10.2196/17338. Online ahead of print.

Brian M Green 1, Katelyn Tente Van Horn 1, Ketki Gupte 1, Megan Evans 2, Sara Hayes 1, Amrita Bhowmick 1 2

177

Safety of Repository Corticotropin Injection as an Adjunctive Therapy for the Treatment of Rheumatoid Arthritis

Expert Opin Drug Saf. 2020 Jun 16;1-10. doi: 10.1080/14740338.2020.1779219.Online ahead of print.

Roy Fleischmann 1, Daniel E Furst 2

178

Adopting PROs in Virtual and Outpatient Management of RA

Nat Rev Rheumatol. 2020 Jun 5;1-2. doi: 10.1038/s41584-020-0449-6. Online ahead of print.

Peter C Talo1

179

Cannabis-based Medicinal Products in Arthritis, a Painful Conundrum

N Z Med J. 2020 May 22;133(1515):35-45.

Marthe Van den Berg 1, Mary John 2, Melissa Black 3, Alex Semprini 4, Karen Oldfield 5, Michelle Glass 6, Irene Braithwaite 4

180

A Mixed Methods Evaluation of an Individualised Yoga Therapy Intervention for Rheumatoid Arthritis: Pilot Study

Complement Ther Med. 2020 May;50:102339.doi: 10.1016/j.ctim.2020.102339.Epub 2020 Feb 6.

Tina Cartwright 1, Margaret Cahill 1, Vidhi Sadana 2

181

Improving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: Focus Group Study

JMIR Form Res. 2020 May 27;4(3):e15158. doi: 10.2196/15158.

Sonali Desai # 1, Emma Stevens 1, Srinivas Emani 2, Peter Meyers 3, Maura Iversen 4, Daniel H Solomon 5

182

Reliability, Feasibility, and Patient Acceptance of an Electronic Version of a Multidimensional Health Assessment Questionnaire for Routine Rheumatology Care: Validation and Patient Preference Study

JMIR Form Res. 2020 May 27;4(5):e15815. doi: 10.2196/15815.

Theodore Pincus 1, Isabel Castrejon 1 2, Mariam Riad 1, Elena Obreja 1, Candice Lewis 1, Niels Steen Krogh 3

183

Patient and Clinician Views on an App for Rheumatoid Arthritis Disease Monitoring: Function, Implementation and Implications

Int J Rheum Dis. 2020 May 18. doi: 10.1111/1756-185X.13850. Online ahead of print.

Rebecca Grainger 1 2, Hermaleigh Roberta Townsley 1, Catherine Anna Ferguson 1, Faye Ellen Riley 1, Tobias Langlotz 3, William John Taylor 1 2

184

Comparison of Infection-Related Hospitalization Risk and Costs in Tumor Necrosis Factor Inhibitor-Experienced Patients With Rheumatoid Arthritis (RA) Treated With Abatacept or Other Targeted Disease-Modifying Anti-Rheumatic Drugs (tDMARDs)

Med Econ. 2020 Jun 13;1-7. doi: 10.1080/13696998.2020.1772271. Online ahead of print.

Damemarie Paul 1, Dhaval Patil 1, Laura McDonald 1, Vardhaman Patel 1, Francis Lobo 1

185

A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFa-Blockade in Rheumatoid Arthritis Patients

Front Immunol. 2020 May 5;11:845. doi: 10.3389/fimmu.2020.00845. eCollection 2020.

Alessandra Nerviani 1, Maria Di Cicco 1, Arti Mahto 1, Gloria Lliso-Ribera 1, Felice Rivellese 1, Georgina Thorborn 1, Rebecca Hands 1, Mattia Bellan 1, Daniele Mauro 1, Marie-Astrid Boutet 1, Giovanni Giorli 1, Myles Lewis 1, Stephen Kelly 1, Michele Bombardieri 1, Frances Humby 1, Costantino Pitzalis 1

186

Siblings of Patients With Rheumatoid Arthritis Have an Increased Mortality Rate: A Swedish Cohort Study

RMD Open. 2020 May;6(1):e001197. doi: 10.1136/rmdopen-2020-001197.

Helga Westerlind 1, Bénédicte Delcoigne 2, Johan Askling 2

187

Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network

 Clin Med 2020 May 19;9(5):E1528.doi: 10.3390/jcm9051528.

Jean-Hugues Salmon 1 2, Jean-Guillaume Letarouilly 3, Vincent Goëb 4, Lukshe Kanagaratnam 1 5, Pascal Coquerelle 6, Marie-Hélène Guyot 7, Eric Houvenagel 8, Nicolas Lecuyer 9, Laurent Marguerie 10, Gauthier Morel 11, Guy Baudens 12, Elisabeth Gervais 13, René-Marc Flipo 3

Free article

188

A Mixed Methods Evaluation of an Individualised Yoga Therapy Intervention for Rheumatoid Arthritis: Pilot Study

Complement Ther Med. 2020 May;50:102339.doi: 10.1016/j.ctim.2020.102339.Epub 2020 Feb 6.

Tina Cartwright 1, Margaret Cahill 1, Vidhi Sadana 2

Affiliations collapseAffiliations

189

Prevalence of COVID-19 Among Patients With Chronic Inflammatory Rheumatic Diseases Treated With Biologic Agents or Small Molecules: A Population-Based Study in the First Two Months of COVID-19 Outbreak in Italy

Joint Bone Spine. 2020 May 20;S1297-319X(20)30088-9. doi: 10.1016/j.jbspin.2020.05.003.Online ahead of print.

Luca Quartuccio 1, Francesca Valent 2, Enrico Pasut 3, Carlo Tascini 4, Salvatore De Vita 5

190

Disease Activity and Patient-Reported Outcomes in Patients With Rheumatoid Arthritis and Sjögren

Rheumatol Int. 2020 May 24. doi: 10.1007/s00296-020-04602-8. Online ahead of print.

Leslie R Harrold 1 2, Ying Shan 3, Sabrina Rebello 3, Neil Kramer 4, Sean E Connolly 5, Evo Alemao 5, Sheila Kelly 5, Joel M Kremer 6, Elliot D Rosenstein 4

191

Modifiable Lifestyle Factors Associated With Response to Treatment in Early Rheumatoid Arthritis

CR Open Rheumatol. 2020 May 26. doi: 10.1002/acr2.11132. Online ahead of print.

Zoe Brown 1, Robert Metcalf 1, Jana Bednarz 2, Llewellyn Spargo 1, Anita Lee 1, Catherine Hill 3, Mihir Wechalekar 4, Christiana Stavrou 5, Michael James 1, Les Cleland 3, Susanna Proudman 3

192

Tranexamic Acid Does Not Reduce the Risk of Transfusion in Rheumatoid Arthritis Patients Undergoing Total Joint Arthroplasty

Arthroplasty. 2020 Apr 18;S0883-5403(20)30383-1.doi: 10.1016/j.arth.2020.04.029.Online ahead of print.

Kyle W Morse 1, Nicole K Heinz 1, Jeremy M Abolade 1, Joshua I Wright-Chisem 1, Linda A Russell 2, Meng Zhang 3, Serene Z Mirza 2, Dana E Orange 4, Mark P Figgie 1, Peter K Sculco 1, Susan M Goodman 2

193

Comparison of Infection-Related Hospitalization Risk and Costs in Tumor Necrosis Factor Inhibitor-Experienced Patients With Rheumatoid Arthritis (RA) Treated With Abatacept or Other Targeted Disease-Modifying Anti-Rheumatic Drugs (tDMARDs)

 Med Econ. 2020 May 19;1. doi: 10.1080/13696998.2020.1772271. Online ahead of print.

Damemarie Paul 1, Dhaval Patil 1, Laura McDonald 1, Vardhaman Patel 1, Francis Lobo 1

194

CD28 - Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status

Front Med (Lausanne). 2020 May 5;7:129. doi: 10.3389/fmed.2020.00129. eCollection 2020.

Charlotte Thompson 1 2, Ruth Davies 1, Anwen Williams 1, Gareth Jones 1 3, Ernest H S Choy 1

195

Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases: A Systematic Review and Meta-analysis

JAMA Dermatol. 2020 May 20;e201300. doi: 10.1001/jamadermatol.2020.1300.Online ahead of print.

Shamarke Esse 1 2, Kayleigh J Mason 2, Adele C Green 2 3 4, Richard B Warren 2

196

Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Rheumatol. 2020 May 18. doi: 10.1002/art.41316. Online ahead of print.

Michael F Robinson 1, Nemanja Damjanov 2, Bojana Stamenkovic 3, Goran Radunovic 2, Alan Kivitz 4, Lori Cox 5, Zorayr Manukyan 6, Christopher Banfield 6, Michael Saunders 6, Deepa Chandra 5, Michael S Vincent 5, Jessica Mancuso 7, Elena Peeva 5, Jean S Beebe 5

197

Chronic Diarrhoea and Risk of Rheumatoid Arthritis: Findings From the French E3N-EPIC Cohort Study

Rheumatology (Oxford). 2020 May 17;keaa133. doi: 10.1093/rheumatology/keaa133.Online ahead of print.

Yann Nguyen 1 2, Xavier Mariette 3 4, Carine Salliot 1 5, Gaëlle Gusto 1 6, Marie-Christine Boutron-Ruault 1 6, Raphaèle Seror 3 4

198

Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?

Neuroimmune Pharmacol. 2020 May 15;1-7. doi: 10.1007/s11481-020-09923-w.Online ahead of print.

Priyanka Pahan 1, Kalipada Pahan 2 3

199

Temporary Interruption of Baricitinib: Characterization of Interruptions and Effect on Clinical Outcomes in Patients With Rheumatoid Arthritis

Paul Emery 1, Yoshiya Tanaka 2, Tracy Cardillo 3, Douglas Schlichting 3, Terence Rooney 3, Scott Beattie 3, Cameron Helt 3, Josef S Smolen 4

200

Safety of the Zoster Vaccine Recombinant Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center

ACR Open Rheumatol. 2020 May 15. doi: 10.1002/acr2.11150. Online ahead of print.

Emma Stevens 1, Michael E Weinblatt 1, Elena Massarotti 1, Frances Griffin 1, Srinivas Emani 2, Sonali Desai 1

201

Anxiety and Depression in Reproductive Age Women With Rheumatic Diseases

Rheumatol Int. 2020 May 5. doi: 10.1007/s00296-020-04591-8. Online ahead of print.

Cassandra Michele Skinner-Taylor 1, Lorena Perez-Barbosa 2, Maria Eugenia Corral-Trujillo 1, Itzel Perez-Onofre 1, Eugenio Salvador Barriga-Maldonado 1, Jesus Alberto Cardenas-de la Garza 1, Janett Riega-Torres 1, Dionicio Angel Galarza-Delgado 1

202

Estimation of Minimally Important Differences and Patient Acceptable Symptom State Scores for the Patient-Reported Outcomes Measurement Information System Pain Interference Short Form in Rheumatoid Arthritis

ACR Open Rheumatol. 2020 May 9.doi: 10.1002/acr2.11141. Online ahead of print.

Patricia Katz 1, Carol L Kannowski 2, Luna Sun 2, Kaleb Michaud 3

203

Adalimumab Dose Tapering in Patients With Rheumatoid Arthritis Who Are in Long-Standing Clinical Remission: Results of the Phase IV PREDICTRA Study

Ann Rheum Dis. 2020 May 13;annrheumdis-2020-217246.doi: 10.1136/annrheumdis-2020-217246. Online ahead of print.

Paul Emery 1 2, Gerd R Burmester 3, Esperanza Naredo 4, Luigi Sinigaglia 5, Ivan Lagunes 6, Franziska Koenigsbauer 7, Philip G Conaghan 8 2

204

Rheumatoid Meningitis: Clinical Characteristics, Diagnostic Evaluation, and Treatment

Neurohospitalist. 2020 Apr;10(2):88-94.doi: 10.1177/1941874419859769. Epub 2019 Jun 30.

Angela M Parsons 1, Fawad Aslam 2, Marie F Grill 1, Allen J Aksamit 3, Brent P Goodman 1

205

Real-World Outcomes Associated With Triple Therapy Versus TNFi/MTX Therapy

Arthritis Care Res (Hoboken). 2020 May 6. doi: 10.1002/acr.24253. Online ahead of print.

Jeffrey R Curtis 1, J Lynn Palmer 2, George W Reed 3, Jeffrey Greenberg 4, Dimitrios A Pappas 5, Leslie R Harrold 3, Joel M Kremer 4

206

Rheumatology Is Exiting the Age of "Can We" (We Certainly Can) and Now Must Entertain the Question "Should We"?

Arthritis Care Res (Hoboken). 2020 May 6. doi: 10.1002/acr.24247. Online ahead of print.

Bruce Rothschild 1

207

Management of Fatigue in Rheumatoid Arthritis

MD Open. 2020 May;6(1):e001084. doi: 10.1136/rmdopen-2019-001084.

Janet E Pope 1

208

Collaboration in Hand Surgery: Experiences From Silicone Arthroplasty in Rheumatoid Arthritis, Finger Replantation and Amputation Challenges in Assessing Impairment, Satisfaction, and Effectiveness, Wrist and Radius Injury Surgical Trial, and Surgery of the Ulnar Nerve

J Am Acad Orthop Surg. 2020 Apr 27. doi: 10.5435/JAAOS-D-20-00102. Online ahead of print.

Robert L Kane 1, Kevin C Chung

209

High Serum Interleukin-6 Is Associated With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or Methotrexate in a Post Hoc Analysis

Arthritis Rheumatol. 2020 Apr 28. doi: 10.1002/art.41299. Online ahead of print.

Anita Boyapati 1, Sergio Schwartzman 2, Jérôme Msihid 3, Ernest Choy 4, Mark C Genovese 5, Gerd R Burmester 6, Gordon Lam 7, Toshio Kimura 1, Jonathan Sadeh 8 9, David M Weinreich 1, George D Yancopoulos 1, Neil M H Graham 1

210

Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study

J Clin Med. 2020 Apr 24;9(4):E1227.doi: 10.3390/jcm9041227.

Maria Antonietta Barbieri 1, Giuseppe Cicala 1, Paola Maria Cutroneo 2, Elisabetta Gerratana 1, Caterina Palleria 3, Caterina De Sarro 3, Ada Vero 3, Luigi Iannone 3, Antonia Manti 3, Emilio Russo 3, Giovambattista De Sarro 3, Fabiola Atzeni 1, Edoardo Spina 1

211

Tapering of Biological Antirheumatic Drugs in Rheumatoid Arthritis Patients Is Achievable and Cost-Effective in Daily Clinical Practice: Data From the Brussels UCLouvain RA Cohort

Arthritis Res Ther. 2020 Apr 28;22(1):96.doi: 10.1186/s13075-020-02165-4.

Stéphanie Dierckx 1, Tatiana Sokolova 1, Bernard R Lauwerys 1, Aleksandra Avramovska 1, Laurent Meric de Bellefon 1, Adrien Nzeusseu Toukap 1, Maria Stoenoiu 1, Frédéric A Houssiau 1, Patrick Durez 2

212

Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series

J Clin Rheumatol. 2020 Apr 25. doi: 10.1097/RHU.0000000000001370. Online ahead of print.

Nilasha Ghosh 1 2, Michael D Tiongson 3, Carolyn Stewart 2, Karmela K Chan 1 2, Bridget Jivanelli 1, Laura Cappelli 4, Anne R Bass 1 2

213

The Microbiome in Rheumatology: Where Are We and Where Should We Go?

Rheum Dis. 2020 Apr 24;annrheumdis-2019-216631.doi: 10.1136/annrheumdis-2019-216631. Online ahead of print.

Julia Manasson 1, Rebecca B Blank 1, Jose U Scher 2

214

Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019

JAMA Netw Open. 2020 Apr 1;3(4):e203969. doi: 10.1001/jamanetworkopen.2020.3969.

Alexandra Erath 1, Stacie B Dusetzina 2

215

Precision Medicine With Leflunomide: Consideration of DHODH Haplotype and Plasma Teriflunomide Concentration Can Substantially Modify Outcomes in Patients With Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2020 Apr 27. doi: 10.1002/acr.24236. Online ahead of print.

Michael D Wiese 1 2, Ashley M Hopkins 3, Catherine King 1 4, Mihir D Wechalekar 3 5, Anita Lee 6 7, Llewellyn Spargo 6, Robert Metcalf 6, Leah McWilliams 6, Catherine Hill 6 7 8, Leslie G Cleland 6, Susanna M Proudman 6 7

Affiliations collapse

216

A Qualitative Metasynthesis of the Experience of Fatigue Across Five Chronic Conditions

Pain Symptom Manage. 2019 Dec 20;S0885-3924(19)31063-2.

doi: 10.1016/j.jpainsymman.2019.12.358. Online ahead of print.

Rosario B Jaime-Lara 1, Brittany C Koons 2, Lea Ann Matura 2, Nancy A Hodgson 2, Barbara Riegel 2

217

The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients With Rheumatoid Arthritis: Results From a Prospective Cohort Study

Nancy A Shadick 1, Patricia Katz 2, Christine I Iannaccone 1, Gabriela Maica 1, Jonathan Coblyn 1, Michael E Weinblatt 1, Jing Cui 1

ACR Open Rheumatol. 2019 Oct 24;1(10):620-626.

 doi: 10.1002/acr2.11088.eCollection 2019 Dec.

218

Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis

ACR Open Rheumatol. 2019 Oct 26;1(10):627-631. doi: 10.1002/acr2.11083.eCollection 2019 Dec.

Michael D Richter 1, Eric L Matteson 1, John M Davis 3rd 1, Sara J Achenbach 1, Cynthia S Crowson 1

219

Effectiveness and Safety Over 3 Years After the 2-year U-Act-Early Trial of the Strategies Initiating Tocilizumab and/or Methotrexate

Rheumatology (Oxford). 2019 Dec 20;kez602. doi: 10.1093/rheumatology/kez602.Online ahead of print.

Maxime M A Verhoeven 1, Janneke Tekstra 1, Paco M J Welsing 1, Attila Pethö-Schramm 2, Michelle E A Borm 3, George A W Bruyn 4, Reinhard Bos 5, Ed N Griep 6, Ruth Klaasen 7, Jacob M van Laar 1, Floris P J G Lafeber 1, Johannes W J Bijlsma 1, Marjolein J H de Hair 1, Johannes W G Jacobs 1

220

Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage

Tatangelo M1,2, Tomlinson G1,2, Paterson JM1,3, Ahluwalia V4, Kopp A3, Gomes T1,3,5, Bansback N6, Bombardier C1,2. JAMA Netw Open. 2019 Dec 2;2(12):e1917053. doi: 10.1001/jamanetworkopen.2019.17053.

221

The roles of post-diagnosis accumulation of morbidities and lifestyle changes on excess total and cause-specific mortality risk in rheumatoid arthritis

Yoshida K1,2, Lin TC1, Wei M3, Malspeis S1, Chu SH1,2,4, Camargo CA2,4,5, Raby BA2,6,7, Choi HK2,8, Tedeschi SK1,2, Barbhaiya M9,10, Lu B1,2, Costenbader KH1,2, Karlson EW1,2, Sparks JA1,2. Arthritis Care Res (Hoboken). 2019 Dec 7. doi: 10.1002/acr.24120. [Epub ahead of print]

222

Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study

Strand V1, van der Heijde D2, Tanaka Y3, Keystone E4, Kremer J5, Zerbini CAF6, Cardiel MH7, Cohen S8, Nash P9, Song YW10, Tegzová D11, Gruben D12, Wallenstein G13, Connell CA12, Fleischmann R8; ORAL Scan investigators. Clin Exp Rheumatol. 2019 Dec 19. [Epub ahead of print]

223

Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication

Mohamed MF1, Klünder B2, Othman AA3. Clin Pharmacokinet. 2019 Dec 23. doi: 10.1007/s40262-019-00855-0. [Epub ahead of print]

224

Artificial intelligence in detecting early RA

Stoel BC1. Semin Arthritis Rheum. 2019 Dec;49(3S):S25-S28. doi: 10.1016/j.semarthrit.2019.09.020.

225

Origins of rheumatoid arthritis

Boissier MC1, Biton J2, Semerano L3, Decker P2, Bessis N2. Joint Bone Spine. 2019 Dec 5. pii: S1297-319X(19)30175-7. doi: 10.1016/j.jbspin.2019.11.009. [Epub ahead of print]

226

Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials

Keystone EC1, Ahmad HA2, Yazici Y3, Bergman MJ4. Rheumatology (Oxford). 2019 Dec 9. pii: kez455. doi: 10.1093/rheumatology/kez455. [Epub ahead of print]

227

Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelae

McWilliams DF1,2,3, Rahman S1,2,3, James RJE1,4, Ferguson E1,3,4, Kiely PDW5, Young A6, Walsh DA1,2,3,7. BMC Rheumatol. 2019 Nov 18;3:49. doi: 10.1186/s41927-019-0100-9. eCollection 2019.

228

A quarter of patients time their early rheumatoid arthritis onset differently than physicians

Ellingwood L1, Kudaeva F1, Schieir O2, Bartlett SJ3,4, Bessette L5, Boire G6, Hazlewood GS7, Hitchon C8, Keystone E9, Tin D10, Thorne C11, Bykerk VP12,13, Pope J1; CATCH Investigators. RMD Open. 2019 Nov 14;5(2):e000931. doi: 10.1136/rmdopen-2019-000931. eCollection 2019.

229

Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis

Curtis JR1, Xie F2, Kay J3, Kallich JD4. Arthritis Res Ther. 2019 Dec 12;21(1):285. doi: 10.1186/s13075-019-2022-8.

230

Insulin Resistant Pathways are associated with Disease Activity in Rheumatoid Arthritis and are Subject to Disease Modification through Metabolic Reprogramming; A Potential Novel Therapeutic Approach

Gallagher L1,2, Cregan S1, Biniecka M3, Cunningham C2, Veale DJ3, Kane DJ1, Fearon U2, Mullan RH1. Arthritis Rheumatol. 2019 Dec 16. doi: 10.1002/art.41190. [Epub ahead of print]

231

Low Muscle Density is Associated with Deteriorations in Muscle Strength and Physical Functioning in Rheumatoid Arthritis

Baker JF1,2,3, Mostoufi-Moab S4, Long J5, Taratuta E6, Leonard MB5, Zemel B4. Arthritis Care Res (Hoboken). 2019 Dec 16. doi: 10.1002/acr.24126. [Epub ahead of print]

232

Obstructive lung diseases and risk of rheumatoid arthritis

Friedlander HM1, Ford JA1,2, Zaccardelli A1, Terrio AV1, Cho MH2,3,4, Sparks JA1,2. Expert Rev Clin Immunol. 2020 Jan;16(1):37-50. doi: 10.1080/1744666X.2019.1698293. Epub 2020 Jan 6.

233

Rheumatoid arthritis and risk of spontaneous abortion: a Danish nationwide cohort study

Nathan NO1,2, Mørch LS2, Wu CS3,4, Olsen J5,6, Hetland ML7,8, Li J5, Rom AL1,2. Rheumatology (Oxford). 2019 Nov 27. pii: kez565. doi: 10.1093/rheumatology/kez565. [Epub ahead of print]

234

Patient Perspectives on Switching from Infliximab to Infliximab-dyyb in Patients with Rheumatologic Diseases in the United States

Chau J1, Delate T2, Ota T2, Bhardwaja B3. ACR Open Rheumatol. 2019 Mar 15;1(1):52-57. doi: 10.1002/acr2.1007. eCollection 2019 Mar.

235

The Self-Administered Rheumatoid Arthritis Disease Activity Index (RADAI) is Less Accurate than DAS28-CRP as a Disease Activity Measure in Pregnancy

Smeele HTW1, Naterop J1, Röder E1, Hazes JMW1, Dolhain RJEM1. ACR Open Rheumatol. 2019 Mar 30;1(2):97-103. doi: 10.1002/acr2.1012. eCollection 2019 Apr.

236

Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort study

Cannon GW1,2, Erickson AR3, Teng CC1,4, Huynh T1,4, Austin S1,5, Wade SW6, Stolshek BS7, Collier DH8, Mutebi A7, Sauer BC1,4. Rheumatol Adv Pract. 2019 May 28;3(1):rkz015. doi: 10.1093/rap/rkz015. eCollection 2019.

237

Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs

Strand V1, Schiff M2, Tundia N3, Friedman A4, Meerwein S5, Pangan A4, Ganguli A4, Fuldeore M4, Song Y6, Pope J7. Arthritis Res Ther. 2019 Dec 2;21(1):263. doi: 10.1186/s13075-019-2059-8.

238

Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort study

Yates M1, MacGregor AJ2, Ledingham J3, Norton S4, Bechman K1, Dennison EM5, Galloway JB1. Rheumatology (Oxford). 2019 Dec 5. pii: kez550. doi: 10.1093/rheumatology/kez550. [Epub ahead of print]

239

Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

Strand V1, Pope J2, Tundia N3, Friedman A4, Camp HS4, Pangan A4, Ganguli A4, Fuldeore M4, Goldschmidt D5, Schiff M6. Arthritis Res Ther. 2019 Dec 9;21(1):272. doi: 10.1186/s13075-019-2037-1.

240

Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA

Hamann PDH1, Pauling JD2, McHugh N2, Hyrich K3,4, Shaddick G5. Rheumatology (Oxford). 2019 Nov 12. pii: kez518. doi: 10.1093/rheumatology/kez518. [Epub ahead of print]

241

Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race

Roberts MH1, Erdei E2. Autoimmun Rev. 2020 Jan;19(1):102423. doi: 10.1016/j.autrev.2019.102423. Epub 2019 Nov 14.

242

Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis

Burmester GR1, Gordon KB2, Rosenbaum JT3, Arikan D4, Lau WL4, Li P4, Faccin F4, Panaccione R5. Adv Ther. 2020 Jan;37(1):364-380. doi: 10.1007/s12325-019-01145-8. Epub 2019 Nov 20.

243

Reasons for b/tsDMARD cessation and persistence of second line treatment in a large real world rheumatoid arthritis dataset

Youssef P1, Marcal B1, Button P1, Truman M1, Bird P1, Dip G1, Griffiths H1, Roberts L1, Tymms K1, Littlejohn G1. J Rheumatol. 2019 Dec 1. pii: jrheum.190535. doi: 10.3899/jrheum.190535. [Epub ahead of print]

244

The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease

Inoue D7, Kawano M8, Khosroshahi A9, Lanzillotta M10, Okazaki K11, Perugino CA12, Sharma A13, Saeki T14, Schleinitz N15, Takahashi N16, Umehara H17, Zen Y18, Stone JH19; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3.

245

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians

Bendstrup E1, Møller J1, Kronborg-White S1, Prior TS1, Hyldgaard C2. J Clin Med. 2019 Nov 21;8(12). pii: E2038. doi: 10.3390/jcm8122038.

246

Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis

Spivey CA1, Winthrop KL2, Griffith J3, Kaplan CM4, Qiao Y1, Postlethwaite AE5, Wang J6. Rheumatol Ther. 2020 Mar;7(1):133-147. doi: 10.1007/s40744-019-00184-5. Epub 2019 Nov 18.

247

Interstitial Lung Disease as the Initial Manifestation of Rheumatoid Arthritis: A Case Report and Review of the Literature

Singh K1, Al-Sadawi M1, Ortega RR1, Akter K1, Zrodlowski T1, Zmijewski C1, McFarlane IM1. Am J Med Case Rep. 2019;7(12):342-347. doi: 10.12691/ajmcr-7-12-10. Epub 2019 Oct 28.

248

Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis

Schäfer M1, Meißner Y1, Kekow J2,3, Berger S4, Remstedt S5, Manger B6, Listing J1, Strangfeld A1, Zink A1,7. Rheumatology (Oxford). 2019 Nov 20. pii: kez535. doi: 10.1093/rheumatology/kez535. [Epub ahead of print]

249

Supplementing Claims Data with Electronic Medical Records to Improve Estimation and Classification of Rheumatoid Arthritis Disease Activity: A Machine Learning Approach

Feldman CH1, Yoshida K1, Xu C1, Frits ML1, Shadick NA1, Weinblatt ME1, Connolly SE2, Alemao E2, Solomon DH1. ACR Open Rheumatol. 2019 Sep 4;1(9):552-559. doi: 10.1002/acr2.11068. eCollection 2019 Nov.

250

Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data

Emery P1, Furst DE2,3,4, Kirchner P5, Melega S5, Lacey S6, Lehane PB7.

251

Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years

Pope JE1, Keystone E2, Jamal S3, Wang L4, Fallon L5, Woolcott J5, Lazariciu I6, Chapman D7, Haraoui B8. ACR Open Rheumatol. 2019 Mar 28;1(2):73-82. doi: 10.1002/acr2.1010. eCollection 2019 Apr.

252

Safety of Abatacept Versus Placebo in Rheumatoid Arthritis: Integrated Data Analysis of Nine Clinical Trials

Simon TA1, Soule BP1, Hochberg M2, Fleming D1, Torbeyns A3, Banerjee S1, Boers M4. ACR Open Rheumatol. 2019 May 29;1(4):251-257. doi: 10.1002/acr2.1034. eCollection 2019 Jun.

253

The Impact of Frailty on Changes in Physical Function and Disease Activity Among Adults With Rheumatoid Arthritis

Andrews JS1, Trupin L2, Wysham KD3, Hough CL1, Yelin EH2, Katz PP2. ACR Open Rheumatol. 2019 Jul 28;1(6):366-372. doi: 10.1002/acr2.11051. eCollection 2019 Aug.

254

Joint Estimation of Remission and Response for Methotrexate-Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta-Analysis

Pokharel G1, Deardon R1, Barnabe C1, Bykerk V2, Bartlett SJ3, Bessette L4, Boire G5, Hitchon CA6, Keystone E7, Pope J8, Schieir O7, Tin D9, Thorne C9, Hazlewood GS1; Canadian Early Arthritis Cohort (CATCH) Investigators, Baron M1,2,3,4,5,6,7,8,9, Bessette L1,2,3,4,5,6,7,8,9, Boire G1,2,3,4,5,6,7,8,9, Bykerk V1,2,3,4,5,6,7,8,9, Colmegna I1,2,3,4,5,6,7,8,9, Fallavollita S1,2,3,4,5,6,7,8,9, Haaland D1,2,3,4,5,6,7,8,9, Haraoui P1,2,3,4,5,6,7,8,9, Hazlewood G1,2,3,4,5,6,7,8,9, Hitchon C1,2,3,4,5,6,7,8,9, Jamal S1,2,3,4,5,6,7,8,9, Joshi R1,2,3,4,5,6,7,8,9, Keystone E1,2,3,4,5,6,7,8,9, Nair B1,2,3,4,5,6,7,8,9, Panopoulos P1,2,3,4,5,6,7,8,9, Penney C1,2,3,4,5,6,7,8,9, Pope J1,2,3,4,5,6,7,8,9, Rubin L1,2,3,4,5,6,7,8,9, Thorne C1,2,3,4,5,6,7,8,9, Villeneuve E1,2,3,4,5,6,7,8,9, Zummer M1,2,3,4,5,6,7,8,9. ACR Open Rheumatol. 2019 Aug 8;1(8):471-479. doi: 10.1002/acr2.11052. eCollection 2019 Oct.

255

Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis

Reed GW1,2, Gerber RA3, Shan Y4, Takiya L5, Dandreo KJ4, Gruben D3, Kremer J6, Wallenstein G3. Rheumatol Ther. 2019 Nov 9. doi: 10.1007/s40744-019-00177-4. [Epub ahead of print]

256

Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials

Smolen J1, Fleischmann R2, Aletaha D3, Li Y4, Zhou Y4, Sainsbury I5, Galindo IL4. Arthritis Res Ther. 2019 Nov 10;21(1):231. doi: 10.1186/s13075-019-2005-9.

257

2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis

Barber CEH1, Zell J2, Yazdany J3, Davis AM4, Cappelli L5, Ehrlich-Jones L6, Everix D7, Thorne JC8, Bohm V1, Suter L9, Limanni A10, Michaud K11. Arthritis Care Res (Hoboken). 2019 Dec;71(12):1531-1539. doi: 10.1002/acr.24040. Epub 2019 Nov 11.

258

2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures

England BR1, Tiong BK2, Bergman MJ3, Curtis JR4, Kazi S5, Mikuls TR1, O'Dell JR1, Ranganath VK2, Limanni A6, Suter LG7, Michaud K8. Arthritis Care Res (Hoboken). 2019 Dec;71(12):1540-1555. doi: 10.1002/acr.24042. Epub 2019 Nov 11.

259

An Analysis of Real-World Data on the Safety of Etanercept in Older Patients with Rheumatoid Arthritis

Edwards CJ1, Bukowski JF2, Burns SM3, Jones HE2, Pedersen R2, Sopczynski J2, Marshall L2. Drugs Aging. 2020 Jan;37(1):35-41. doi: 10.1007/s40266-019-00721-5.

260

The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis

Peterson S1, Piercy J2,3, Blackburn S2, Sullivan E2, Karyekar CS1, Li N1. BMC Rheumatol. 2019 Oct 28;3:43. doi: 10.1186/s41927-019-0092-5. eCollection 2019.

261

A biopsychosocial network model of fatigue in rheumatoid arthritis: a systematic review

Geenen R1, Dures E2,3. Rheumatology (Oxford). 2019 Nov 1;58(Supplement_5):v10-v21. doi: 10.1093/rheumatology/kez403.

262

The role of non-pharmacological interventions in the management of rheumatoid-arthritis-related fatigue

Cramp F1. Rheumatology (Oxford). 2019 Nov 1;58(Supplement_5):v22-v28. doi: 10.1093/rheumatology/kez310.

263

Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study

Simon TA1, Boers M2, Hochberg M3, Baker N4, Skovron ML4, Ray N5, Singhal S5, Suissa S6, Gomez-Caminero A4. Arthritis Res Ther. 2019 Nov 8;21(1):228. doi: 10.1186/s13075-019-1992-x.

264

Coronary microvascular dysfunction in rheumatoid arthritis compared to diabetes mellitus and association with all-cause mortality

Liao KP1, Huang J1, He Z1, Cremone G1, Lam E1, Hainer JM2, Morgan V2, Bibbo C2, Di Carli M2,3. Arthritis Care Res (Hoboken). 2019 Nov 9. doi: 10.1002/acr.24108. [Epub ahead of print]

265

Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis

Walsh JA1, Pei S2, Penmetsa GK1, Sauer BC2, Patil V2, Walker JH3, Clewell J3, Douglas KM3, Clegg DO1, Cannon GW1, Halwani A4. J Manag Care Spec Pharm. 2019 Nov;25(11):1218-1228. doi: 10.18553/jmcp.2019.25.11.1218

266

Patient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results

Bartlett SJ1,2, De Leon E2,3, Orbai AM2, Haque UJ2, Manno RL2, Ruffing V2, Butanis A2, Duncan T2, Jones MR2, Leong A4, Perin J5, Smith KC3, Bingham CO2. Rheumatology (Oxford). 2019 Oct 30. pii: kez506. doi: 10.1093/rheumatology/kez506. [Epub ahead of print]

267

Pregnancy and rheumatoid arthritis

Littlejohn EA1. Best Pract Res Clin Obstet Gynaecol. 2019 Oct 9. pii: S1521-6934(19)30136-1. doi: 10.1016/j.bpobgyn.2019.09.005. [Epub ahead of print]

268

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension

Burmester GR1, Strand V2, Rubbert-Roth A3, Amital H4, Raskina T5, Gómez-Centeno A6, Pena-Rossi C7, Gervitz L8, Thangavelu K9, St John G10, Boklage S10, Genovese MC11. RMD Open. 2019 Oct 18;5(2):e001017. doi: 10.1136/rmdopen-2019-001017. eCollection 2019

269

Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

Strand V1, Mysler E2, Moots RJ3, Wallenstein GV4, DeMasi R5, Gruben D4, Soma K4, Iikuni N6, Smolen JS7, Fleischmann R8. RMD Open. 2019 Oct 1;5(2):e001040. doi: 10.1136/rmdopen-2019-001040. eCollection 2019